Risky decision-making in the Context of Contingency Management for Methamphetamine Use Disorder by Lake, Marilyn Toni
i 
Risky decision-making in the Context of Contingency Management for 
Methamphetamine Use Disorder 
Marilyn Toni Lake 
(LKXMAR002) 
A minor dissertation submitted in partial fulfillment of the requirements for the award of the 
degree of Masters in Psychological Research 
Faculty of the Humanities 
University of Cape Town 
2019  
Supervisors: Gosia Lipinka and Jonathan C. Ipser 
COMPULSORY DECLARATION 
This work has not been previously submitted in whole, or in part, for the award of any degree. It 
is my own work.  Each significant contribution to, and quotation in, this dissertation from the work, 
or works, of other people has been attributed, and has been cited and referenced. 
Signature:  Date: 29/01/2019 
Un
ive
sit
y o
f C
ap
e T
ow
n
  
 
 
 
 
 
 
 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 
of the non-exclusive license granted to UCT by the author. 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
ii 
 
Acknowledgements 
My gratitude goes to several individuals and organizations that either provided me with the 
opportunity to execute my research project, and/or supported me in conveying my findings: 
 
Firstly, a huge thanks go to my supervisors, Gosia Lipinska and Jonathan Ipser, for their 
dedicated and tireless efforts in assisting me with the conceptualization, analysis and write-up of 
my master’s dissertation. Particular mention goes to Jonathan Ipser for his vital contributions to 
the conceptualization of my project, and to Gosia Lipinska for her extensive contributions to the 
organization and readability of my dissertation.  
 
Additional thanks go to the entire Contingency Management team, both the South African and 
American branches, for their commitment to and expertise on the broader study. From the South 
African team at the University of Cape Town (UCT), massive thanks go to Lara van Nunen for 
her tireless work as a Principal Investigator on the Contingency Management study, brilliantly 
managing the day-to-day operations of the study and ensuring high quality data. In addition, 
thanks extend to Jonathan Ipser and Dan Stein for their expertise given on the study, with special 
thanks to Dan Stein for his role in connecting South African and American teams. From the 
American team at the University of California, Los Angeles (UCLA), thanks are given to Steve 
Shoptaw and Edythe London for their valuable input and expertise on the study. Research 
assistants on the project, Renier Swart and Gert Coetzee, are thanked for their assistance with 
data collection on the project.  
 
I would also like to thank the following people for their contributions to my recently written 
manuscript that is based on my master’s dissertation work (currently under review), which 
include: Edythe London, Steve Shoptaw, Jonathan Ipser, Sae Takada, Lara van Nunen, Gosia 
Lipinska and Dan Stein. 
 
I would also like to thank the participating drug clinics for graciously providing our team access 
to both potential candidates and facilities to conduct our research. Special thanks go to the staff 
members for their enthusiasm in getting involved in the project, and willingness to assist us.  
 
For making the Contingency Management project possible in the first place, thanks go to the 
National Institute of Health (NIH) and the UCT Department of Psychiatry and Mental Health for 
funding of the broader study. For personal funding of my masters, thanks are extended to UCT 
Department of Psychiatry and Mental Health, Oppenheimer Memorial Trust and Ernst and Ethel 
Erikson Trust.  
 
Immense gratitude is also extended to my friend and colleague, Kira Dusterwald, for her efforts 
in editing and proofreading the final draft of my master’s dissertation.   
 
Thanks go to my family and partner, William Crawford, for their unrelenting support and 
patience over these last 3 years of my masters.  
 
And finally, thanks go to all participants who enrolled in the study, without which this work 
would not be possible.  
iii 
 
Abbreviations 
ANCOVA  Analysis of Covariance 
BART   Balloon Analogue Risk Task 
CBT   Cognitive Behavioural Therapy 
CM   Contingency Manage 
CTDCC  Cape Town Drug Counselling Center 
GLMM  Generalized Linear Mixed-effects Model 
HIV   Human Immunodeficiency Virus 
IGT   Iowa Gambling Task 
LMIC   Low-to middle-income country 
LMM   Linear Mixed-effects Model 
LMM-GC  Linear Mixed-effects Growth Curve Model 
LR   Likelihood Ratio 
MUD   Methamphetamine Use Disorder 
PEBL   Psychology Experiment Building Language  
RDM   Risky decision-making  
SANCA South African National Council on Alcoholism and Drug 
Dependence 
SCID-5  Structured Clinical Interview for DSM-5 
UPPS-P  Urgency, Premeditation (lack of), Perseverance (lack of),   
    Sensation Seeking, Positive Urgency, Impulsive Behavior Scale 
vmPFC  Ventromedial Prefrontal Cortex 
WASI   Wechsler Abbreviated Scale of Intelligence 
iv 
 
Table of Contents 
 
Acknowledgements ........................................................................................................ ii 
Abbreviations ................................................................................................................ iii 
Table of Contents .......................................................................................................... iv 
List of Figures ............................................................................................................. viii 
List of Tables................................................................................................................. ix 
Abstract ...........................................................................................................................x 
CHAPTER ONE: INTRODUCTION ..............................................................................1 
CHAPTER TWO: LITERATURE REVIEW ...................................................................4 
Substance Dependence Theories of RDM ........................................................................4 
Incentive-sensitization theory. ..............................................................................4 
Opponent process theory of motivation. ...............................................................5 
Premorbid Vulnerabilities to Substance Use Disorder and RDM ......................................7 
Impulsivity. ..........................................................................................................7 
Risk-taking propensity. ........................................................................................8 
RDM Deficits in MUD ....................................................................................................9 
Reward sensitivity & loss insensitivity. ................................................................9 
Reward and loss magnitude. ................................................................... 10 
Reward and loss frequency. .................................................................... 10 
Diminished risk learning. ........................................................................ 11 
IOWA Gambling Task (IGT). ..................................................... 12 
Balloon Analogue Risk Task (BART). ........................................ 13 
RDM and Treatment Interventions for Substance Use Disorder ..................................... 14 
Research Aim and Hypotheses ....................................................................................... 15 
1.Group differences in baseline RDM and impulsivity at baseline ...................... 16 
2.Baseline RDM and impulsivity as predictors of CM treatment outcomes 
amongst MUD participants................................................................................. 16 
CHAPTER THREE: STUDY DESIGN, METHOD & MATERIALS ............................ 17 
Design and Setting ............................................................................................. 17 
Participants ........................................................................................................ 17 
Eligibility criteria. .................................................................................. 20 
v 
 
Measures ............................................................................................................ 22 
Screening measures. ............................................................................... 22 
Wechsler Abbreviated Scale of Intelligence (WASI). .................. 22 
Structured Clinical Interview for DSM-5 (SCID-5). .................... 23 
Urine testing. .............................................................................. 24 
RDM measures. ...................................................................................... 24 
Iowa Gambling Task (IGT). ........................................................ 24 
Balloon Analogue Risk Task (BART). ........................................ 27 
Impulsivity measures. ............................................................................. 30 
UPPS-P. ...................................................................................... 30 
Procedure ........................................................................................................... 30 
Recruitment. ........................................................................................... 30 
Baseline screening and assessments. ....................................................... 31 
MUD participants. ...................................................................... 31 
Healthy controls. ......................................................................... 32 
CM treatment period for MUD participants. ........................................... 32 
MUD participants. ...................................................................... 32 
Healthy controls. ......................................................................... 33 
Compensation. ........................................................................................ 33 
MUD participants. ...................................................................... 33 
Healthy controls. ......................................................................... 34 
Statistical Analyses ............................................................................................ 34 
Hypothesis 1a. ........................................................................................ 36 
Magnitude effect. ........................................................................ 37 
IGT analysis 1.1. ............................................................. 37 
Frequency effect. ........................................................................ 38 
IGT analysis 1.2. ............................................................. 38 
Risk learning. .............................................................................. 39 
IGT analysis 1.3. ............................................................. 39 
BART analysis 1.4. ......................................................... 40 
Risk-taking propensity. ............................................................... 42 
BART analysis 1.5. ......................................................... 42 
vi 
 
Hypothesis 1b ......................................................................................... 42 
Hypothesis 2 ........................................................................................... 43 
CHAPTER FOUR: RESULTS ...................................................................................... 45 
Group Matching on Demographics ..................................................................... 45 
Covariates of RDM ............................................................................................ 46 
Main Analyses Findings ..................................................................................... 49 
Hypothesis 1a. ........................................................................................ 49 
Magnitude effect. ........................................................................ 49 
IGT analysis 1.1. ............................................................. 49 
Frequency effect. ........................................................................ 53 
IGT analysis 1.2. ............................................................. 53 
Risk learning. .............................................................................. 55 
IGT analysis 1.3. ............................................................. 55 
BART analysis 1.5 .......................................................... 56 
Risk-taking propensity. ............................................................... 58 
BART analysis 1.6. ......................................................... 58 
Hypothesis 1b. ........................................................................................ 59 
Magnitude effect. ........................................................................ 59 
IGT analysis 2.1. ............................................................. 59 
Frequency effect. ........................................................................ 59 
IGT analysis 2.2. ............................................................. 59 
Risk-learning. ............................................................................. 60 
IGT analysis 2.3. ............................................................. 60 
BART analysis 2.4. ......................................................... 60 
Risk-taking propensity. ............................................................... 60 
BART analysis 2.5. ......................................................... 60 
Hypothesis 2. .......................................................................................... 61 
CM treatment effect analysis 3.1...................................... 61 
CHAPTER FIVE: DISCUSSION .................................................................................. 63 
RDM Features .................................................................................................... 64 
Reward and loss magnitude. ................................................................... 64 
Reward and loss sensitivity. ........................................................ 67 
vii 
 
Loss sensitivity in healthy populations. ....................................... 70 
Reward and loss frequency. .................................................................... 71 
Learning. ................................................................................................ 73 
Risk-taking propensity. ........................................................................... 77 
Impulsivity and RDM ........................................................................................ 78 
Sex as a Covariate of RDM ................................................................................ 80 
Predictors of CM Treatment Outcomes .............................................................. 81 
Relapse occurrence. ................................................................................ 81 
Relapse severity. ..................................................................................... 82 
Study strengths and limitations ........................................................................... 83 
CHAPTER SIX: CONCLUSION .................................................................................. 85 
References ..................................................................................................................... 86 
Appendix A ............................................................................................................... 1077 
Appendix B ............................................................................................................... 1098 
Appendix C ............................................................................................................... 1109 
 Appendix D……………………………………………………………………………..110 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
viii 
 
List of Figures 
Figure 1. Screenshot of PEBL version of IGT…………………………………………………25 
Figure 2. E-prime 2.0 version screenshot of high-risk, red balloon trial on BART……………28 
Figure 3. E-prime 2.0 version screenshot of low-risk, blue balloon explosion on BART……..29 
Figure 4. Magnitude effect and learning on IGT……………………………………………….50  
Figure 5. Mean deck selections on IGT………………………………………………………...52 
Figure 6. Frequency effect on IGT……………………………………………………………..54 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
List of Tables 
Table 1. IGT deck outcome specifications………………………………………………………26 
Table 2. IGT deck outcome profiles and associated scoring methods…………………………..40  
Table 3. Sociodemographic, individual and substance-related factors in total sample (N= 45)...48  
Table 4. Magnitude effect on IGT at baseline: LMM estimates…………………………………51 
Table 5. Magnitude effect on IGT at baseline: Group contrasts from LMM …………………...51 
Table 6. Frequency effect on IGT at baseline: LMM estimates…………... ……………………54 
Table 7. Frequency effect on IGT at baseline: Group contrasts from LMM ……………………55 
Table 8. Risk learning on IGT at baseline: LMM-GC estimates…………...……………………56 
Table 9. Risk learning on IGT at baseline: Group contrasts from LMM-GC……………………56 
Table 10. Risk learning on BART at baseline: GLMM estimates………….……………………58 
Table 11. Risk-taking propensity on BART at baseline: ANCOVA estimates………….………59 
Table 12. Hurdle prediction model of CM treatment effect……………………………………..62  
Table 13. Correlations between RDM features and sociodemographic, individual and substance-
related factors…………………………………………………………………………………...107 
Table 14. Model comparisons for Hypotheses 1a and 1b………………………………………108 
Table 15. Between-block learning on IGT at baseline…………………………………………109 
Table 16. Model comparisons for CM treatment effect………………………………………...110 
 
 
 
 
 
 
x 
 
 
Abstract 
Background: Risky decision-making is strongly implicated in adverse real-world risk-taking 
behaviour, and is associated with Substance Use Disorder, including Methamphetamine Use 
Disorder. Laboratory neurocognitive tasks typically utilized to assess risky decision-making have 
been able to distinguish participants with Substance Use Disorder from controls, although 
considerable heterogeneity is still evident within substance-using populations, which remains 
largely unexplained. Preliminary evidence has also tied risky decision-making to treatment 
outcomes, although no research has investigated risk-decision-making within Methamphetamine 
Use Disorder in the context of Contingency Management treatment.   
Methods: This study aimed to investigate decision-making on the Iowa Gambling Task and the 
Balloon Analogue Risk at baseline as both a function and predictor of treatment response on an 
8-week treatment of Contingency Management. Of 26 participants with Methamphetamine Use 
Disorder, 17 responded to Contingency Management treatment, whilst 9 were non-responders. 
Using various mixed-effect modelling techniques and ANCOVA, performance by non-
responders were compared to responders, as well as a group of 19 healthy, nonsubstance-using 
control participants.  
Results:  Group differences between non-responders, responders and controls were exclusively 
obtained on the Iowa Gambling Task. A trend-level (p=.051), large effect size (g=-0.98) was 
observed in the effect of reward magnitude between non-responders and healthy controls. More 
specifically, non-responders tended to seek-out large short-term rewards in spite of long-term 
losses relative to controls, however, groups did not also differ in effect of short-term loss 
magnitude. Non-responders also appeared to demonstrate poorer learning than healthy controls, 
xi 
 
although this finding was also at trend-level (p=.081) with a medium effect size (g =-0.63). In 
addition, results showed that responders and non-responders were differentially influenced by the 
frequency of outcomes, where responders demonstrated a greater preference for frequent rewards 
and infrequent losses relative to non-responders. This difference was at trend-level (p=.053) and 
the effect was moderately sized (g =-0.74). Impulsivity did not moderate group differences in 
decision-making, but did positively predict a greater likelihood of relapse at least once during 
Contingency Management (p =.035), although this effect was small (OR=1.10). Poor overall 
performance on the IGT appeared to predict a greater likelihood of prolonged relapse on 
Contingency Management following initial relapse, although this was at trend-level (p =.071) 
with a small effect size (OR=1.80).  
Conclusion: Findings provide evidence for individual differences in risky decision-making 
within Methamphetamine User Disorder, suggesting that risky decision-making is unlikely to be 
a homogeneous characteristic of substance-using populations, as is typically treated in the 
literature. Risky decision-making may also act as a risk factor for poor treatment success on 
Contingency Management, which in turn suggests that assessing risky decision-making of 
individuals with Methamphetamine Use disorder prior to commencing Contingency 
Management treatment might assist in identifying those at high risk. 
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CHAPTER ONE: INTRODUCTION 
Substance Use Disorder is strongly associated with deficits in decision-making. Some of 
these deficits have been specifically linked to excessive risk-taking, represented by a range of 
conducts, including criminality and risky sexual behaviour (Bechara & Damasio, 2002; Semple, 
Patterson & Grant, 2004; Watt et al., 2014). Methamphetamine is an example of an illicit 
substance associated with risky behaviours, and Methamphetamine Use Disorder (MUD) is 
prevalent amongst low-income communities in the Western Cape, South Africa (Plüddemann, 
Myers & Parry, 2008). The high prevalence of MUD and its strong connection to risky 
behaviours has in turn increased the public health burden in the region, and has propelled 
research efforts towards better understanding risky decision-making (RDM) within MUD, as 
well as the potential adverse implications RDM might have for treatment.  
 Risk-taking can be defined as the selection of actions or choices tied to probabilistic 
outcomes, where the outcomes can potentially result in harm or loss (Leigh, 1999). In this 
dissertation, risk-taking is encompassed within RDM. RDM is defined as the tendency to adopt 
maladaptive actions or choices about unknown probabilistic outcomes that are typically 
associated with direct loss or foregone gain, with limited learning of outcome probabilities across 
sequential choices (Pleskac, 2008). Moreover, RDM represents more than just maladaptive risk-
taking behaviour, as it also subsumes neurocognitive and motivational processes (Bechara et al., 
2001; Bechara & Damasio, 2002; Verdejo-Garcia, Perez-Garcia & Bechara, 2006). 
Neurocognitive tasks such as the Iowa Gambling Task (IGT) have been utilized to assess 
RDM because of their ability to distinguish the performance of substance-using samples from 
non-substance-using samples, whilst also being able to partially attribute impaired performance 
to neurocognitive deficits in both the ventromedial prefrontal cortex (vmPFC) and amygdala  
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(Bechara et al., 2001; Bechara, Dolan & Hindes, 2002; Grant, Contoreggi & London, 2000). 
Poor performance by substance-using samples on neurocognitive gambling tasks has been 
strongly associated with real-world risk-taking behaviours including but not limited to sharing 
needle paraphernalia and engaging in unprotected sexual intercourse (Rajasingham et al., 2012; 
Semple et al., 2004). In particular, both of these behaviours are associated with increased risk of 
transmitting bodily fluid-borne diseases like the human immunodeficiency virus (HIV), whilst 
unprotected sex also exposes individuals to sexually transmitted diseases. Moreover, 
methamphetamine use has specifically been linked to an increased likelihood of exhibiting 
aggressive behaviour (Mcketin et al., 2014).  
Whilst real-world risk-taking within Substance Use Disorder is associated with 
problematic behaviours, excessive risk-taking may also be tied to an increased likelihood of 
initiating substance use. Specifically, premorbid impulsivity and high risk-taking propensity can 
predispose one to risky behaviour, which can increase the prospect of initial engagement in drug 
use (Verdejo-Garcia, Lawrence & Clark, 2008). Moreover, once the development of the 
Substance Use Disorder is established, the risk of relapse is more likely, partly because decision-
making is compromised by pervasive drug-seeking behaviour as the combined result of factors 
involved in substance dependence as well as premorbid impulsivity and risk-taking propensity 
(Koob & Le Moal, 2001).  
In a large study drawing MUD participants from various treatment programs in Los 
Angeles, Brecht & Herbeck (2014) found that more than 50% of MUD individuals relapsed 
within 1-year following treatment. Nevertheless, Contingency Management (CM), a substance 
use treatment intervention designed to positively reinforce abstinence with monetary incentives, 
has proven to be particularly successful in reducing relapse and attrition rates in MUD samples, 
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as well as other substance types (Shoptaw et al., 2005; Prendergast, Podus, Finney, Greenwell & 
Roll, 2006). Although there is extensive literature demonstrating RDM differences between 
various substance-using and healthy control groups, less is known about how RDM profiles of 
patients with Substance Use Disorder may potentially relate to treatment success. Moreover, the 
specific RDM profiles amongst MUD individuals within the context of CM are even further 
unexplored.  
 This dissertation will specifically focus on RDM of MUD participants in the context of 
CM treatment. However, broader trait vulnerability and neurobiological models of substance-
dependency will also be drawn upon in order to identify underlying RDM deficits relevant to 
MUD. Substance dependence and trait vulnerability models will be discussed in the order of 
incentive-sensitization theory, opponent process theory, impulsivity and risk-taking propensity. 
Moreover, this will be followed by discussion of underlying RDM deficits in MUD, including 
reward and loss sensitivity and their ties to reward and loss magnitude, reward and loss 
frequency, and learning: with examples provided from the Iowa Gambling Task (IGT) and 
Balloon Analogue Risk Task (BART).  
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CHAPTER TWO: LITERATURE REVIEW 
Substance Dependence Theories of RDM  
 Incentive-sensitization theory. Robinson and Berridge (1993) introduced the incentive-
sensitization theory to describe how substance usage can potentially lead to substance 
dependence and maintain maladaptive decision-making patterns, particularly in relation to 
Substance Use Disorder. The theory asserts that alterations in neurochemical processes within 
reward neural circuitry produced by prolonged substance use underlie RDM in individuals 
suffering from Substance Use Disorder. This occurs specifically by increasing the incentive 
salience of drug-related cues over prosocial reward cues. Sensitization is thought to emerge from 
reward circuits that encompass dopaminergic pathways through the striatum which become 
increasingly sensitized to drug stimuli and drug-related cues with prolonged substance use 
(Berridge, 2007). In extension, incentive-sensitization theory proposes that neurobiological 
sensitization leads substance users to continue using substances as a result of an emerged 
generalizable sensitivity to drug-related reward cues over and above the drug itself, in turn 
increasing the likelihood of relapse.  
 Everitt and Robbins (2016) argue that the mechanism by which sensitization through 
Substance Use Disorder develops is via a shift of dopaminergic activation from the ventral 
striatum, involved in generating pleasurable phenomenological states associated with 
recreational use, towards the dorsal striatum, involved in eliciting drug-seeking behaviours to 
avoid or diminish aversive phenomenological states as substance use becomes more regular. 
Furthermore, sensitization of reward-related circuitry has been tied to diminished learning 
capacity: where instrumental, goal-directed learning associated with ventral striatal functioning 
is substituted for habitual, compulsive behaviour linked to dorsal striatal activity with prolonged 
5 
 
substance use (Everitt & Robbins, 2016). This further supports the idea that decision-making 
becomes riskier with drug use, because actions are not adequately weighed up with potential 
consequences but are rather automatically driven. Such prepotent reward-seeking responses are 
likely to lead to the negative consequences associated with risky drug-related behaviour (Everitt 
& Robbins, 2016; Gowin, Mackey & Paulus, 2013). 
 Opponent process theory of motivation. Alternate theories of substance dependence, 
including the opponent process theory of motivation, have also been drawn upon to explain risky 
substance usage. First put forward by Solomon and Corbit (1978), the opponent process theory 
of motivation asserts that substance dependence results from neuroadaptations that disrupt the 
maintenance of homeostatic brain functioning. More specifically, the opponent process theory 
purports that there are two interconnected, functionally opposed systems, including: tolerance 
(“a-process”) and withdrawal (“b-process”) systems, which ordinarily operate together in order 
to maintain brain state equilibrium. However, prolonged substance usage can induce over-
compensatory responses within these systems that maintain unregulated brain states, which in 
turn further engender future substance usage.  
 The “a-process” system is characterized by neuroadaptations to dopaminergic neural 
circuitry encompassed within the basal forebrain and ventral striatum, which are associated with 
producing a pleasurable phenomenological state following drug usage. More specifically, the 
neural system causes a diminished response with similar ingested magnitudes of a substance 
following repeated substance use: this underlies the development of tolerance (Koob, Moal, Le 
& Se, 2008). Tolerance refers to the gradual decline in pleasurable affective response elicited 
from equivalent amounts of an addictive substance, and is one way by which an unregulated 
brain state can be categorized (Solomon & Corbit., 1978). As such, the tolerance process 
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increases the likelihood of one engaging in more excessive drug use, namely with use of larger 
magnitudes of a substance, which further increases the likelihood of one experiencing adverse 
consequences associated with substance use (Mata, Hau, Papassotiropoulos & Hertwig, 2012). 
Combining “a-process” and incentive-sensitization theories allows one to explain the escalation 
and chronicity of substance use. The former is best explained by the “a-process”, which drives 
one to seek out greater magnitudes of a substance to counteract the influence of tolerance, whilst 
the latter is explained by the incentive-sensitization theory, that heightens one’s sensitivity to 
drug-related cues and further compounds the likelihood of engaging in future substance use.   
 Conversely, Koob et al. (2008) argue that the “b-process” system is located in the brain’s 
stress response system involved in the release of corticotrophin–releasing factor, adrenalin and 
dynorphin. The release of these hormones generates an opposing, adverse withdrawal state 
during or following the removal of a pleasurable phenomenological state associated with the “a-
process”, where withdrawal is largely characterized as an aversive phenomenological state. 
Increased risky drug-taking is also more likely to take place during withdrawal states, given that 
these states increase the likelihood of drug-seeking as a form of negative reinforcement. More 
importantly, with prolonged use of an addictive substance, withdrawal states following drug use 
persist long after the initial consumption of the drug, increasing the likelihood of future drug use. 
Following from this, in the withdrawal state, additional non-drug-related losses that are 
experienced can be better endured. This is due to the fact that loss experienced over and above 
the current aversive withdrawal state has diminished impact on the state itself. This diminished 
subjective experience of loss can further increase the likelihood of drug-taking, as weighting of 
potential loss outcomes tied to drug-taking are discounted within the decision-making process.  
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Premorbid Vulnerabilities to Substance Use Disorder and RDM 
Impulsivity. Ersche et al. (2005) argue that Substance Use Disorder could emerge from 
premorbid neurobiological vulnerabilities. In fact, a susceptibility to impulsive behavior has been 
strongly tied to increased predisposition to Substance Use Disorder (Ersche, Turton, Pradhan, 
Bullmore & Robbins, 2010). Any reference to vulnerability/susceptibility to impulsive behaviour 
in the dissertation will be merely referred to as “impulsivity.” Impulsivity is regarded as a 
multidimensional construct, but there is a lack of consensus around its different facets, with 
definitions varying based on both proposed measure and associated conceptualization. In 
general, impulsivity is defined as any behavior characterized by a tendency to act rashly or 
“without-thinking” in response to rewarding stimuli (Leigh, 1999) 
Impulsivity is argued to emerge from activity associated with the same subcortical neural 
structures implicated in incentive-sensitization theory, including the striatum and amygdala. In 
fact, Everitt (2014) argues that reward neurocircuitry are overly responsive to reward stimuli 
prior to any use of substances, biasing individuals to engage in drug use for its subjectively 
rewarding effects. With prolonged substance use, these neural circuits become “hijacked,” where 
activation becomes particularly elevated in the presence of drug and drug-related stimuli. 
Interestingly, impulsivity is particularly associated with stimulant use (Ersche et al., 2010), but 
also increases the likelihood of demonstrating RDM.  
In addition, impulsivity aligns strongly with “hot” over “cold” cognition, where the 
former refers to affective-driven processing, whilst the latter involves more deliberate, higher-
order processing. Impulsivity is related to more deficient, affective-driven type behaviour, during 
which potential negative consequences associated with an action are not accounted for fully. In 
terms of methamphetamine use, Semple, Zians, Grant and Patterson (2005) found that highly 
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impulsive MUD participants displayed greater amounts of risky behaviour than less impulsive 
MUD individuals, where risky behaviour was defined by both the number of sexual partners and 
cases of unprotected sexual intercourse. A relatively greater incidence of risky behaviours 
amongst impulsive MUD participants is thought to reflect, in part, a diminished ability to 
account for potential negative consequences when making decisions. Furthermore, susceptibility 
to Substance Use Disorder and RDM may also partially emerge from premorbid trait-level 
decision-making factors. 
Risk-taking propensity. Risk-taking propensity refers to the extent to which one will 
typically preference riskier choices/actions associated with greater outcome variability relative to 
safer choices/actions with less outcome variability (Schonberg, Fox, Poldrack, 2011). 
Methamphetamine users and other substance-using populations typically demonstrate greater 
risk-taking propensity relative to healthy controls, where riskier choices that are associated with 
greater potential reward but also greater potential loss are favoured over safer options with 
relatively more certain but smaller rewards and losses (Upton, Bishara, Ahn & Stout, 2011) 
Like impulsivity, a high risk-taking propensity is, in part, thought to emerge from a 
neurobiological sensitivity to reward that precedes chronic substance use but can also be 
heightened as a result of chronic substance use (Aklin et al., 2009). Risky decisions can be made 
impulsively or “without thought,” yet decisions can also be made consciously and deliberately, 
suggesting a partial overlap of neurobiological mechanisms underlying impulsivity and risk-
taking propensity (Upton et al., 2011). MUD participants are also more likely to demonstrate 
both a greater risk-taking propensity as well as a predisposition to impulsive behaviour relative 
to healthy individuals (Mahoney et al., 2015). Finally, high risk-taking propensity is directly 
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related to RDM in that it underlies a general preference for riskier choices, increasing the 
likelihood of presenting RDM.   
RDM Deficits in MUD 
Reward sensitivity & loss insensitivity. Whilst substance dependency and premorbid 
vulnerability theories may explain the development of risky, prolonged substance use several 
authors have demonstrated that MUD participants are more likely to exhibit risky behaviour in 
areas other than substance use behaviour (Gonzalez, Bechara & Martin, 2007; van der Plas, 
Crone, van den Wildenberg, Tranel & Bechara, 2010). Both neurobiological vulnerabilities and 
alterations due to chronic use may enhance tendencies for RDM through altered reward and loss 
sensitivity (Bechara & Damasio, 2002). MUD participants demonstrate heightened reward 
sensitivity, where actions are biased towards reward stimuli (Ahn et al. 2014; Kohno, Morales, 
Ghahremani, Hellemann & London, 2014). Heightened reward sensitivity is in agreement with 
specific theories on susceptibility to impulsive behaviour, where quick action is taken in the 
presence of rewarding stimuli. Moreover, it closely aligns with incentive-sensitization and 
opponent process theory. Specifically, sensitization of drug and drug-related stimuli may explain 
increased sensitivity to drug-related reward stimuli, whilst unregulated emotional states in 
opponent process theory may explain the drive toward rewarding stimuli as a means to seek-out 
pleasurable phenomenological states (i.e. positive reinforcement) and/or counteract withdrawal 
(i.e. negative reinforcement).  
Substance-using populations also demonstrate diminished loss reactivity, which refers to 
a relatively reduced subjective aversion to losses and diminishes the impact of loss in influencing 
decision-making (Verdejo-Garcia & Bechara, 2009). Moreover, a diminished loss reactivity may 
be explained by the same theories that explain increased reward sensitivity. In relation to the 
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incentive sensitization theory, neurobiological alterations prioritize the detection of reward over 
loss outcomes which may result in insufficient processing of loss outcomes. Diminished loss 
reactivity could also be underlined by opponent process theories, in which dysregulated states of 
tolerance and withdrawal can diminish processing prioritization of losses. This is because such 
dysregulated states strengthen the pre-potent drive towards rewarding stimuli as an attempt to 
adjust towards a homeostatic state. Furthermore, deficient reward and loss processing may 
specifically promote RDM via the presence of large reward and loss outcomes. 
 Reward and loss magnitude. RDM amongst MUD participants is more likely when 
rewards are larger, and this is apparent even in the presence of concurrent large losses (van der 
Plas et al., 2010). The sensitivity towards large rewards makes sense in relation to substance 
dependence theories, in that tolerance mechanisms combined with incentive sensitization 
processes can explain the sensitization towards larger over smaller rewards. Specifically, MUD 
participants may be continually driven to obtain larger-sized rewards to counteract tolerance 
processes that may blunt subjective experience of pleasure derived for smaller-sized rewards. 
Moreover, sensitization is demonstrated when choice options associated with large gains become 
favoured, and act as reward cues that increase the likelihood of future RDM.   
Reward and loss frequency. Whilst the literature on gambling task performance within 
substance-using populations has largely focused on the influence of sensitivity to reward 
magnitude on decision-making, Horstmann, Villringer and Neumann (2012) argue that it is 
important to disentangle effects of frequency from magnitude, especially in gambling tasks with 
sequential choice and uncertain outcomes. In such tasks, one’s choices may be influenced by one 
or a combination of preferences for the frequency and magnitude of a choice option. Research is 
lacking with respect to effects of reward and loss frequency relative to magnitude on RDM 
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amongst MUD participants. However, on a risk task in which obese, alcohol-using and 
methamphetamine-using groups chose between a sure and a risky choice on reward and loss 
outcomes, Voon et al. (2015) found that abstinent MUD participants demonstrated a greater 
preference for larger, infrequent rewards relative to smaller, frequent rewards. This suggests that 
RDM by MUD individuals may not just be influenced by effects of magnitude, but also effects 
of frequency.  Moreover, MUD participants were found to avoid large, infrequent losses in place 
of smaller, frequent losses. This is contrary to other findings by Gowin, Stewart et al. (2013), 
who found that MUD participants were more likely to make risky choices following losses. This 
inconsistency in findings may have arisen because comparisons in the study by Voon et al. 
(2015) were not made in relation to a healthy control group, but rather other clinical populations 
who might also be expected to demonstrate RDM deficits.   
Despite this, Voon et al. (2015) were the first to assess the potential impact of the 
combination of both outcome magnitude and frequency on RDM amongst MUD participants, 
using a risky choice task. This has not been fully investigated with regards to other gambling 
tasks such as the Iowa Gambling Task (IGT) and in relation to a healthy control group. Given the 
lack of research on sensitivity to outcome frequency amongst MUD individuals, it is still not 
clear to what extent effects of reward and loss frequency may be linked to neurobiological 
models of substance dependency and premorbid vulnerability. However, these models do 
account for compromised learning amongst methamphetamine-using populations.  
Diminished risk learning. Heightened reward sensitivity and diminished loss reactivity 
can influence RDM through risk learning, which can be demonstrated by continuous poor 
performance over time by MUD participants relative to healthy controls on various gambling 
tasks that incorporate uncertain probabilistic outcomes, and which require learning of such 
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probabilities through experience (Kohno et al., 2014; Schonberg et al., 2011). Of the various 
gambling tasks employed to measure features of RDM under uncertainty, the IGT and the 
Balloon Analogue Risk Task (BART) represent two popular measures of real-world risk-taking. 
 IOWA Gambling Task (IGT). The IGT has been consistently able to differentiate 
performance between substance users and non-substance users (Bishara et al., 2009; Ashenhurst, 
Bujarski, Jentsch & Ray, 2014). Moreover, the IGT has also been able to confirm significant 
differences between specific substance-using populations, including MUD participants 
(Gonzalez et al., 2007). First developed by Bechara, Damasio, Damasio and Anderson (1994), a 
computerised version of the IGT involves the selection of cards from various decks, where cards 
from each deck consist of a reward value that is presented with every card selected from that 
particular deck, in addition to a simultaneous loss value that emerges probabilistically over 
time.  Each deck is defined by a specific reward and loss magnitude, as well as a certain 
probability of loss. In turn, each deck is associated with a specific long-term pay-out, and the aim 
is to determine the long-term average pay-out associated with each deck, and select those decks 
that maximize long-term gains. Half of the decks are considered to be more advantageous with 
smaller immediate gains but greater long-term net gains. Conversely, the remaining decks are 
associated with larger short-term gains but are considered to be relatively disadvantageous, as 
selection for such decks result in a long-term net loss. On the IGT, the probabilities of “winning” 
and “losing” across decks is not made known to the participant and it is up to the participant to 
learn through experience to shift from risky, disadvantageous decks to more conservative, 
advantageous decks. In this way, given the uncertainty of outcomes, risk learning is obtained 
through experience on the first few deck selections.  
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 Several studies have found that substance users typically do not learn to shift from 
disadvantageous decks to advantageous decks over time, leading to relatively poorer 
performances relative to healthy samples (Bishara et al., 2009; Bechara et al., 2002). However, 
given that a reward from a deck selection is experienced simultaneously with a loss, it is unclear 
to what extent RDM is driven by increased reward sensitivity or diminished loss sensitivity. 
Additionally, RDM on the IGT may be exacerbated by a tendency to act impulsively (Franken, 
van Strien, Nijs & Muris, 2008). 
Balloon Analogue Risk Task (BART). Lejuez et al. (2002) developed the Balloon 
Analogue Risk Task (BART) as an alternative cognitive behavioural measure to self-report 
assessments of risk-taking. The BART involves inflating a virtual balloon to acquire monetary 
credit at the risk of potentially exploding the balloon and losing total accrued credit on that 
particular trial (Lejuez et al., 2002). Importantly, the explosion probability is not known by the 
participant and the explosion probability increases with each inflation (Fukunaga, Brown & 
Bogg, 2013). In this way, participants must use trial-by-trial experience to learn balloon 
explosion probabilities, in order to pump such as to maximize accrued monetary credit on the 
task.  
Lejuez et al. (2002) have found riskier performance by smokers relative to healthy 
controls on BART, where smokers demonstrated both a higher pump average, in addition to a 
higher number of explosions. However, subsequent findings by Dean, Sugar, Hellemann and 
London (2011), have demonstrated reduced pumping of smokers relative to controls. Hellemann 
& London, 2011; Kohno et al., 2014). It is not entirely clear how these findings relate to MUD 
populations in particular, but Kohno et al. (2014) found that MUD participants did not 
significantly differ from healthy controls in average pumps.  
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RDM and Treatment Interventions for Substance Use Disorder 
The strong relationship between RDM and MUD participants is particularly relevant 
when considering the adverse impact of RDM deficits on success in treatment (Chen, Chen & 
Wang, 2015). This is supported by Taymoori and Pashaei (2016), who demonstrated that higher 
RDM can adversely impact one’s success on a matrix treatment programme for 
methamphetamine use, by increasing the likelihood of relapse. In particular, high risk-taking 
propensity at baseline, as traditionally scored on the BART, has been found to predict future 
relapse amongst methamphetamine users (Taymoori & Pashaei, 2016). However, limited 
research to date has investigated RDM by MUD individuals in the context of Contingency 
Management (CM). 
CM is a substance use behavioral intervention that positively reinforces abstinence; it has 
been shown to be a promising treatment intervention for MUD. In a randomised control trial, 
Shoptaw et al. (2005) found that CM had a higher treatment efficacy than cognitive behavioural-
based treatments (CBT) amongst gay and bisexual methamphetamine–using men, demonstrated 
by a greater number of methamphetamine-free urine samples, increased retention and fewer 
missed urine tests. A similar study comparing CBT and CM found that CM was more effective 
in treating MUD (Roll et al., 2006). Furthermore, CM treatment is particularly relevant to RDM 
amongst MUD participants, as CM treatment directly assesses real-world decision-making tied to 
drug use. This is because MUD participants make decisions regarding drug use that are 
underpinned by associated monetary rewards tied to abstinence and foregone monetary rewards 
(i.e. loss) linked to relapse.  
In summary, several complementary neurobiological and trait models have been 
proposed to underlie RDM in Substance Use Disorder, suggesting that heterogeneous 
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mechanisms may give rise to various manifestations of reward and loss sensitivity deficits in 
RDM. Importantly, these models may account for both heightened reward and loss sensitivity in 
MUD populations compared to healthy controls, as well as variability within MUD populations. 
In fact, previous research has largely focused on only a few of these potential RDM 
manifestations, including biased action in relation to outcome magnitude, but less so on outcome 
frequency. Moreover, a limited number of studies have investigated these RDM features in the 
context of particular substance types, including methamphetamine. Further research is needed to 
identify the particular RDM profiles within MUD populations that may act as potential risk 
factors for poor treatment success, specifically in the context of CM treatment.    
Research Aim and Hypotheses 
This study had two broad aims. The first aim was to investigate whether RDM at baseline 
differed within the MUD group, namely between treatment responder and non-responder 
subgroups, as well as in relation to healthy controls. Non-responders were defined as those MUD 
participants who exhibited at least one methamphetamine-positive urine sample and/or missed 
sample throughout the duration of CM treatment, where a missed sample was considered drug 
positive, in line with previous CM literature (Correia & Benson, 2006; Petry et al., 2004; Rash, 
Alessi, & Petry, 2008). In contrast, responders were defined as those participants who attended 
all appointments and exclusively demonstrated methamphetamine-negative urine samples during 
CM treatment. RDM was assessed by several of its component features, including: effects of 
magnitude, effects of frequency, learning, and risk-taking propensity. This aim was further 
extended to investigate whether impulsivity moderates RDM.  
The second aim of this study was to assess whether baseline RDM and impulsivity 
amongst MUD participants might potentially act as predictors of poor treatment success on CM.  
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My hypotheses were as follows: 
1. Group differences in baseline RDM and impulsivity at baseline 
a. MUD participants, treatment non-responders more so than responders, demonstrate 
greater RDM at baseline relative to healthy controls, where RDM is defined by several features, 
including: the effect of the magnitude of short-term reward and loss outcomes on decision-
making (the magnitude effect), the effect of the frequency of reward and loss outcomes (the 
frequency effect), learning and risk-taking propensity. 
b. Impulsivity positively moderates the relationship between MUD treatment 
response/healthy control groups and baseline RDM, but does not entirely account for potential 
group differences in RDM 
2. Baseline RDM and impulsivity as predictors of CM treatment outcomes amongst 
MUD participants 
a. Amongst MUD participants, greater RDM, alongside greater impulsivity, predicts relapse 
occurrence and relapse severity over the duration of CM treatment.  
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CHAPTER THREE: STUDY DESIGN, METHOD & MATERIALS 
Design and Setting 
 This study formed part of a larger pilot project aimed at investigating the neural 
mechanisms underlying treatment success on CM for MUD. The current study utilized a 
between-groups, cross-sectional, matched case-control design; consisting of MUD and healthy 
control groups. MUD participants were administered test measures at the end of a 2-week 
baseline period, before beginning 8-weeks of CM treatment. The measures were also completed 
by a matched non-substance-using control group, who were included in the study design 
alongside MUD participants in order to describe the spectrum of RDM in a low-income setting, 
where decision-making by the MUD group would presumably differ from controls.  
Participants 
A sample size of 30 MUD and 30 healthy control participants was selected a priori as part 
of the broader pilot study, based on consideration of resource constraints and in line with the 
pilot nature of the study. Using the G*power statistical software program (Erdfelder, Faul & 
Buchner, 1996), a power calculation yielded a power of .80 to detect a large cohen’s f effect size 
of .73 based on a 2-sided hypothesis test with an alpha of .05. All effect sizes were interpreted 
using Cohen’s (1988) classifying convention, with a small effect represented by 0.20, medium as 
0.50 and large as 0.80. An additional power analysis was conducted in order to establish sample 
size requirements for detecting potential group differences in gambling task performance. Given 
the absence of meta-analysis research on gambling task performance amongst MUD samples, a 
large pooled effect size of .99 was taken from Gonzalez et al. (2007) paper, which represents the 
difference in IGT performance between a MUD and healthy control group. In addition, the 
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significance level was set to .05, power was set to .80 and a two-sided hypothesis test was 
utilized. The power calculation inferred a recommendation of a total of 36 participants (18 within 
each group).  
 45 participants (17 female, aged 18-45) participated in the study, which surpassed the 
recommended power calculation. Of 269 methamphetamine-using candidates, 26 MUD 
participants represented the analytic sample of the MUD group in this study. Of 33 participants 
who were actually enrolled in CM treatment, 7 were excluded from the analyses due to the 
following: drop-out prior to completion of CM (2), cocaine use (1), meningitis (1), brain 
abnormality (1), education less than 7 years (1) and a methamphetamine-positive urine sample 
on the day of baseline task assessment (1). 148 candidates were not eligible for reasons 
including: psychiatric comorbidity, chronic medical illness, current use of psychoactive 
medication, MUD condition too severe for outpatient treatment, subthreshold MUD, HIV 
seropositive status, problematic use of certain drugs besides methamphetamine, primary drug of 
choice other than methamphetamine, not treatment-seeking or not committed to completing the 
entire CM treatment programme, under/over the age limit, subthreshold intellectual function, 
neurological illness or traumatic brain injury, left-handed, current pregnancy, claustrophobia, 
metal present within the body, or in recovery (i.e. not a current user of methamphetamine). A 
further 88 recruits were not eligible to partake in the study due to non-attendance of ≥4 
scheduled meetings during the baseline period.  
Of 149 control candidates screened, 19 matched non-substance users made up the 
complete analytical sample for the control group. Control group participants were matched 
against MUD participants using a frequency matching approach of characteristics, that aimed to 
acquire equal group distributions on relevant demographic characteristics such as age, gender, 
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years of education and broad intellectual function. 125 control candidates were not eligible for 
the following reasons: no corresponding match of a particular characteristic within the MUD 
group, psychiatric comorbidity, chronic medical illness, current use of psychoactive medication, 
use of substances other than occasional alcohol or cigarette smoking, left-handed, HIV 
seropositive, not interested in partaking in the study, subthreshold broad intellectual function, 
under/over the age limit, neurological illness or traumatic brain injury. 3 additional control 
candidates were not eligible due to non-attendance of ≥1 scheduled meeting. Of 24 healthy 
control participants who were initially enrolled in the study, 5 participants were removed from 
analysis due to (2) study drop-out, (1) suspected chronic illness, (1) missing data and (1) 
cannabis-positive test on the day of baseline task assessment.  
Despite attempts to match MUD and healthy control groups, gender distribution was 
unbalanced both within the MUD group and between MUD and control groups. Males 
outnumbered females 2:1 within the MUD group, although this disproportion is somewhat 
representative of the gender distribution seen amongst treatment-seeking populations, where 
males typically represent a greater proportion (Myers, Louw & Pasche, 2011). In addition, MUD 
participants were not fully matched against the control group in relation to gender, given that the 
control group consisted of fewer total participants, with males in the MUD group (17) 
outnumbering those in the control group (11).  
 The majority of MUD participants were recruited from outpatient clinics (n=16), 
including: The Cape Town Drug Counselling centre (CTDCC) in Observatory, the South African 
Council of Alcoholism and Drug Dependence (SANCA) in Athlone and Sultan Bahu 
rehabilitation centres in Mitchell’s Plain, Hanover park and Bonteheuwel. Both CTDCC and 
SANCA outpatient clinics offered motivational interviewing as their primary treatment for 
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substance use, whilst Sultan Bahu offered group therapy. In addition, newspaper advertisements 
were utilized to recruit the minority of both MUD participants (n=10) and control group 
participants (n=8). Snowball recruitment strategies were used to obtain the remaining control 
group participants (n = 11), where efforts were placed in recruiting non-substance-using and non-
biological relatives, friends and colleagues of MUD participants.  
Eligibility criteria. 
 (1) Individuals between 18-45 years of age were included in both the MUD and control 
group.  
 (2) MUD participants had to be both primary and chronic users of methamphetamine. 
(Discussed further under “Structured Clinical Interview for DSM-5 (SCID-5)” subsection under 
“Measures”). Secondary use of methaqualone (mandrax), cannabis and/or nicotine was accepted 
due to the high prevalence of concurrent use alongside methamphetamine, especially in South 
Africa (Peltzer, Ramlagan, Johnson & Phaswana-Mafuya, 2010). Problematic use of drugs 
besides methamphetamine, methaqualone, cannabis or nicotine that was either regular and/or 
required treatment (in past two years) was excluded for. In addition, MUD participants were 
eligible if they were current users (Discussed further under “Urine testing” subsection of 
“Measures”). Furthermore, verified abstinence (i.e. methamphetamine-negative test) had to be 
obtained on the day of the baseline task assessment, in order to prevent potential confounding 
acute effects of methamphetamine on gambling task performance (Stough et al., 2012). 
 (3) Conversely, control group individuals had to be non-substance users, given that the 
study sought to compare MUD participants against healthy controls. However, cigarette smoking 
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and occasional alcohol usage was accepted, given the high prevalence of use of these substances, 
especially within low-income populations in South Africa (Dada et al., 2017). 
 (4) MUD participants had to be seeking treatment for current methamphetamine usage 
and must have demonstrated intentions to maintain outpatient treatment in order to be eligible for 
the study. Individuals with MUD that was considered too severe for outpatient treatment were 
not eligible to participate in the study. Only those control participants that were interested in 
partaking in the study, and who were committed to attending all sessions, were eligible.   
 (5) Individuals with current comorbid psychiatric illnesses not induced by substance 
usage were excluded across MUD and control groups. People with substance-induced psychosis 
were additionally excluded, but those with Antisocial Personality Disorder were accepted within 
the MUD group (Discussed further in “Structured Clinical Interview for DSM-5 (SCID-5) 
subsection of “Measures”). 
 (6) Amongst both MUD and control groups, use of psychoactive medication/s was 
exclusionary, given its potential impact on decision-making capabilities (Gendle & Golding, 
2010).  
 (7) Both MUD and control groups had to meet threshold broad intellectual functioning 
(Discussed further under “Wechsler Abbreviated Scale of Intelligence (WASI)” subsection of 
“Measures”). In addition, MUD and control participants needed 7 or more years education (i.e. 
they needed to have completed at least primat school education).  
 (8) Amongst both MUD and control groups, participants with self-reported chronic 
physical illness, neurological illness/s and/or traumatic brain injury were excluded given their 
potential impact on cognitive functioning and brain structure, which could confound treatment 
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outcomes amongst MUD participants and/or decision-making capabilities amongst both MUD 
and control groups (Cotrena, Branco, Zimmermann, Cardoso & Grassi-oliveira, 2014; Fecteau et 
al., 2013). HIV seropositive status was excluded for across MUD and control group given the 
potential impact of HIV on task performance (Gonzalez, Wardle, Jacobus, Vassileva & Martin-
Thormeyer, 2010).  
 (8) Related to objectives of the larger pilot study and requirements for the magnetic 
resonance imaging, presence of metal in the body, current pregnancy and/or claustrophobia was 
excluded for amongst MUD participants. MUD and control participants also had to be right-
handed. 
Measures 
Screening measures. 
Wechsler Abbreviated Scale of Intelligence (WASI). The WASI is a shortened version 
of the more comprehensive Weschler Adult Scale of Intelligence utilized for persons aged 6-89, 
and demonstrates comparable psychometric properties to the full-scale measure (Wymer, Rayls 
& Wagner, 2003). Moreover, the WASI has been found to demonstrate similar validity and 
reliability across both healthy and clinical populations (Wymer et al., 2003). The measure was 
administered to both MUD and control group participants in order to determine individuals’ 
available cognitive capacity to understand and successfully complete computerised gambling 
tasks as well as other self-report measures. A cut-off score of 55 was chosen based on its 
applicability to a low- to middle-income country (LMIC) context, like South Africa’s 
(Shuttleworth-Edwards & van der Merwe, 2016).  
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Considering that study participants predominantly consisted of both English and 
Afrikaans first-language speakers, both an English and validated Afrikaans-translated version of 
the questions were provided for the verbal scale of the WASI. Acceptable reliability, with 
Cronbach alpha values ranging from 0.73-0.84, has been demonstrated across the English and 
Afrikaans versions of the WASI in South Africa (Grieve & van Eeden, 2010).  
 Structured Clinical Interview for DSM-5 (SCID-5). The SCID-5, intended for use by 
researchers, was utilized as a screening tool to establish whether methamphetamine users met the 
criteria for current primary MUD, and is considered the gold standard for clinical interviewing 
and has demonstrated good reliability (Ventura, Liberman, Green, Shaner & Mintz 1998). 
Methamphetamine use was classified as current MUD, based on evidence of methamphetamine 
use over at least the past 12-month period, in addition to meeting several of the criteria laid-out 
in the SCID-5 (American Psychiatric Association, 2013). MUD was considered primary if one 
demonstrated a history of greater use and longer duration of use of methamphetamine relative to 
other substances. If one also demonstrated concurrent secondary use (and not primary use) of 
cannabis and/or methaqualone (mandrax), this was accepted.   
 The SCID-5 was also utilized to exclude for the presence of psychiatric comorbidities 
amongst MUD and control groups. By excluding psychiatric comorbidities, the study is better 
able to isolate unique effects of MUD on task performance and CM treatment success. 
Importantly, methamphetamine-induced psychosis was also excluded for, given its potential for 
confounding treatment outcomes amongst MUD participants and/or affecting cognitive 
capacities required for decision-making tasks amongst both MUD and control groups (Cotton, 
2014). However, antisocial personality disorder was included given that rates of antisocial 
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tendencies are highly prevalent in LMIC countries such as South Africa (Waller, Gardner & 
Cluver, 2018).  
 Urine testing. In order to verify current use of methamphetamine, MUD participants 
underwent a 2-week baseline period, in which urine samples were drawn and tested three times 
per week, with a maximum of 2 days in between urine tests. This particular interval period is 
associated with optimal sensitivity to detect methamphetamine use (i.e. within 48 hours 
following drug use). Two urine tests were conducted at each visit, including tests for 
methamphetamine and d-amphetamine (a methamphetamine metabolite). Testing for d-
amphetamine assisted in validating findings from tests of methamphetamine, in addition to 
extending the detection period from 2 to 3 days. Furthermore, MUD participants were randomly 
tested for 4 additional substances over several occasions, both during the baseline period and 
whilst partaking in CM treatment. These substances included cannabis, cocaine, opiates and 
barbiturates. Conversely, control group participants only underwent urine tests over 2 scheduled 
sessions, namely baseline screening and assessment sessions, in order to verify self-reported non-
substance use. At both sessions, control participants were tested for 6 substances: 
methamphetamine, d-amphetamine, cocaine, cannabis, opiates and barbiturates.    
RDM measures. 
 Iowa Gambling Task (IGT). Developed by Bechara et al. (1994), the IGT is a gambling 
task that measures RDM. The Psychology Experiment Building Language (PEBL) 0.14 
computerised-version of the measure consists of 4 virtual decks, A, B, C and D, in which 
participants make deck selections over a total of 100 trials. When a deck is chosen, one obtains a 
fixed reward on that trial, represented by a monetary reward gained, but one can also obtain a 
concurrent, probabilistic loss (Figure 1). The objective of the task is to maximize total money 
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gained by selecting decks that are associated with positive long-term net pay-outs and avoiding 
decks associated with negative long-term net pay-outs. In particular, decks A and B are 
considered to be disadvantageous decks because they are associated with long-term losses, whilst 
decks C and D are considered more advantageous as they are associated with positive long-term 
gains. 
 
Figure 1. Screenshot of PEBL version of IGT: Deck A has been selected by a participant who 
has subsequently earned $100. Reprinted from “Decision-making in healthy participants on the 
Iowa gambling Task: New insights from an operant approach,” by P.N. Bull, L.J. Tippett, D.R. 
Addis, 2015, Frontiers in Psychology, 6, p.5 
In addition to long-term net pay-out, decks differ from one another in terms of the 
magnitude of reward and loss outcomes presented and the frequency with which rewards and 
losses occur (see Table 1). The task has been designed such that disadvantageous decks with 
long-term losses are also associated with large short-term rewards, whilst advantageous decks 
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are tied to smaller short-term rewards. Rather, long-term net losses on disadvantageous decks are 
explained by relatively higher average loss penalties that exceed their associated large but short-
term gains. Despite the fact that average losses over time in combination with specific short-term 
reward sizes are tied to long-term outcomes, the magnitude of short-term losses is not directly 
tied to particular long-term net pay-outs on this version of the IGT, as they vary in size even 
within both advantageous and disadvantageous decks. Moreover, as only short-term loss 
outcomes vary in both magnitude and frequency across decks, with the magnitude and frequency 
of reward outcomes being fixed for each deck, the net frequency pay-out of rewards relative to 
losses can be calculated. Net frequency is derived from summing the magnitude of a reward and 
loss outcome that occur simultaneously with the selection of a deck, to determine a net value and 
its associated frequency of occurrence over time. Furthermore, performance on the IGT could be 
influenced by any one or all deck characteristics, including magnitude, frequency and/or long-
term pay-out.  
Table 1     
IGT deck outcome specifications 
 
Deck A Deck B Deck C Deck D 
Reward magnitude  100 100 50 50  
Loss magnitude  150- 350 1250 25-75 250  
Long-term average -250 -250 250 250 
Absolute gain-loss frequency  10 gains 
5 losses 
10 gains 
1 loss 
10 gain 
1 loss 
10 gains 
5 losses 
Net gain-loss frequency 9 gains 
5 losses 
9 gains 
1 loss 
9 gains  
5 draws 
9 gains 
1 loss 
 
 Moreover, performance on the IGT can also be impacted by learning ability. Participants 
are not made aware of the long-term outcome contingencies of each deck, but are rather told that 
some decks are more advantageous than others, and that one should select such decks in order to 
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maximize net payout on the task. This suggests that deck outcome contingencies are learnt 
through experience on the task. Moreover, in order to ensure that performance represented 
decision-making capabilities, participants were incentivised with a flat rate voucher to the value 
of R25, if a positive net-payout was obtained on the task. Moreover, the IGT itself has been 
demonstrated in the literature to be both an ecologically valid measure of RDM, given its strong 
association with self-reported real-life RDM, including excess substance usage and sexual risk 
behaviours (Golub, Starks, Kowalczyk, Thompson & Parsons, 2012; Bechara et al., 2001).  
 Balloon Analogue Risk Task (BART). An E-prime 2.0 computerised version of the 
BART (Schneider, Eschman & Zuccolotto, 2002) was used in this study. The task is a valid risk-
taking measure developed by Lejuez et al. (2002). The measure consists of a virtual balloon that 
is electronically “pumped-up” by the participant in order to obtain a virtual monetary reward, 
which is conducted over 40 balloon trials (Figure 2). The aim of this test is for the participant to 
maximise the total amount of monetary reward accrued, which is increased with every pump of 
the balloon, with 5-point increments gained for each pump However, increasing the number of 
pumps in a trial also increases the probability of the balloon exploding, whereby the total reward 
occurred in that particular trial is lost following an explosion (Figure 3). In this way, participants 
must decide how many times to pump the balloon up within one trial (otherwise viewed as how 
much money to “cash-out” within one trial) before moving on to the next trial. Moreover, 
balloons are represented by two different types of risk, with red balloons signifying greater risk 
(higher probability of explosion) and blue balloons representing relatively lower risk (lower 
probability of explosion), although the potential reward obtained on each pump is the same 
across balloon types. Importantly, explosion probabilities for red and blue balloons are 
represented by 1/32 and 1/128 respectively, drawn from a uniform distribution. In this way, each 
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balloon trial is associated with a random explosion probability drawn from within the specified 
probabilistic range.  
Unlike the IGT, the BART has no pre-specified long-term outcomes attached to short-
term actions taken, and outcomes are relatively more sensitive to individual differences. As a 
result of this, the BART better isolates one’s preference for riskier, variable outcomes over safer, 
certain outcomes, otherwise referred to as risk-taking propensity. Moreover, similarly to the IGT, 
participants were not made aware of the explosion probabilities associated with each balloon 
type, which thus allows one to assess learning of balloon explosion probabilities from experience 
on the task. In turn, risk-taking propensity and risk learning can be assessed from performance 
on the BART. Similarly to the IGT, participants received a flat R25 reward voucher for obtaining 
a positive net-payout on the BART. In support of this, Ferrey and Mishra (2014) found that 
performance on the BART by substance users differed when offered real monetary rewards 
relative to hypothetical rewards. This task has been used successfully in the South African 
context comparing risk-taking in psychotic and non-psychotic MUD participants (Cotton, 2014).  
 
 
Figure 2. E-prime 2.0 version screenshot of high-risk, red balloon trial on BART 
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Figure 3. E-prime 2.0 version screenshot of low-risk, blue balloon explosion on BART 
The BART and IGT are complementary tasks in that each task measures risk-taking 
under uncertainty, where outcome probabilities are not made explicitly known to the participant 
but are learnt through experience. However, tasks do differ in their associated outcome 
variability, where risk probabilities in the IGT are relatively more fixed, whilst explosion 
probabilities vary more substantially on the BART. Moreover, the IGT factors in long-term 
outcomes, which is not evident within the BART, and in turn suggests that the BART better 
accounts for unconstrained risk-taking preferences, whereas the IGT assesses the extent to which 
one demonstrates risk learning (Upton et al., 2011). Tied to this, the BART encourages an 
adaptive level of risk–taking whilst the IGT punishes any risk-seeking behaviour (Dean et al., 
2011; Dislich, Zinkernagel, Ortner & Schmitt, 2010). Furthermore, the BART has explicitly pre-
defined the magnitude of reward and loss outcomes, where rewards and losses on the BART are 
directly related to one’s pumping patterns, where the latter is experienced by a loss in accrued 
credit due to balloon explosion whilst the former is represented by successful “cashing-out” on a 
balloon (Bishara et al., 2009). Moreover, whilst rewards and losses on the BART are separated in 
the form of “explosions” and “cash-outs,” reward and loss are experienced simultaneously on the 
IGT.  
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Impulsivity measures. 
 UPPS-P. Otherwise referred to as the Urgency, Premeditation (lack of), Perseverance 
(lack of), Sensation Seeking, Positive Urgency, Impulsive Behavior Scale (UPPS-P), this self-
report instrument measures psychopathological vulnerability to impulsivity as it exists along 5-
dimensions, including namely: lack of premeditation, lack of perseverance, sensation seeking, 
positive urgency and negative urgency (Whiteside & Lynam, 2001). A UPPS-P total score across 
each of the proposed 5-dimensions was calculated and utilized to represent a general 
vulnerability to impulsive behaviour, otherwise referred to as “impulsivity”. The UPPS-P was 
borne from several reliable, but heterogeneous survey instruments, reducing impulsivity to 5 
dimensions and demonstrating high internal consistency (Whiteside & Lynam, 2001). Using the 
UPPS-P, Uhlmann et al. (2016) found that MUD participants with and without psychosis 
demonstrated high impulsivity relative to healthy controls in a South African context.  
Procedure 
 Recruitment. Clinic personnel from partnered rehabilitation clinics were provided with 
an overview of CM treatment, eligibility criteria, as well as posters to be placed up around the 
clinic. I went to the clinics on specified days of the week in order to make contact with 
potentially eligible MUD recruits, where CM treatment was explained in detail, provisional 
eligibility was determined and voluntary informed consent was obtained. For those interested 
MUD and control recruits who responded to newspaper advertisements or who were obtained 
through snowball sampling, I made contact with recruits telephonically in order to explain the 
requirements of the study (and a description of CM treatment for MUD recruits), establish 
provisional eligibility as well as to obtain voluntary consent.  
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Baseline screening and assessments.  
 MUD participants. After establishing eligibility, interest and commitment to partaking in 
the study, regular meetings were set up with MUD participants. These meetings took place at 
Psychiatry department at Groote Schuur Hospital, Cape Town. Participants first underwent a 2-
week baseline period in order to establish their commitment to the program (i.e. attendance at ≥4 
meetings), in addition to ensuring that at least one methamphetamine-positive urine sample was 
obtained to confirm current use of methamphetamine. Meetings were scheduled to take place 
three times a week (every Monday, Wednesday and Friday) in order to ensure that there were no 
more than 2 days between urine tests.  
  Within this 2-week period, a screening session was set-up in order to complete both the 
WASI and SCID-5 screening measures, and took place over a period of 2 hours. If an individual 
did not present with a psychiatric co-morbidity and had an WASI score above 55, they were 
taken for an HIV-test at the drop-in clinic situated at the University of Cape Town, where they 
received pre- and post-test counselling. If a participant was HIV seronegative, a baseline task 
assessment took place towards the end of this same two-week period, where computerized 
gambling tasks (IGT and BART) and a self-report measure were administered over a 1-hour 
period. Two to three days prior to baseline task assessment, urine sample testing was utilized to 
verify abstinence prior to the scheduled day of assessment, and was additionally utilized on the 
day of assessment. If a participant presented with a methamphetamine-positive urine sample on 
the day of assessments, the assessment was re-scheduled.  
Moreover, if an eligible candidate failed to provide at least one methamphetamine-
positive urine sample during the 2-week baseline period (i.e. the presence of methamphetamine 
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and/or d-amphetamine), failed to attend ≥ 4 meetings, or did not meet all the eligibility criteria, 
they were excluded from the study. 
Recruits who provisionally presented with a psychiatric comorbidity were referred for 
further assessment with a psychiatrist at Groote Schuur hospital. Moreover, those who presented 
with an HIV seropositive status were referred to their nearest day clinic for anti-retroviral 
treatment, in addition to further HIV counselling. Candidates in too severe a condition for 
outpatient treatment were referred for inpatient treatment. Importantly, candidates were not told 
that a methamphetamine-positive urine sample was required during the 2-week baseline period in 
order to be eligible for CM treatment, as this could create a potential perverse incentive to use 
methamphetamine as a means to become eligible for CM treatment.  
 Healthy controls. The WASI and SCID-5 were administered to the control group 
participants during a screening session, where a urine test was taken. If a participant obtained a 
score on the WASI equaling or exceeding the 55 cut-off criterion, did not present with any 
psychiatric illnesses, and had a urine test that was negative (“absent”) of any substances, they 
were offered the opportunity to complete computerised gambling tasks (the IGT and BART) and 
self-report measures over one baseline session of 1 hour.  
CM treatment period for MUD participants.  
 MUD participants. Following baseline screening, fully eligible MUD participants 
underwent an 8-week CM treatment period, where they were required to meet three times a week 
on Monday, Wednesday and Friday for urine tests. It was during this period that participants 
could earn vouchers of increasing value with every negative urine sample (i.e. abstinence from 
methamphetamine use) that they provided. Vouchers were sent to the participants’ working cell 
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phone number or on a loaned phone if the participant did not have one and could only be 
redeemed at a large supermarket franchise, Checkers and Checkers hypermarket. 
 Healthy controls. These individuals did not receive CM treatment, and thus were not 
seen during the period over which the intervention was administered to MUD participants, 
besides at the beginning and end of the intervention period.    
Compensation.  
 MUD participants. Throughout the CM treatment period, vouchers were rewarded to 
MUD participants based on methamphetamine-negative test results (i.e. verified abstinence from 
methamphetamine use). Vouchers were sent to participants via mobile phone, and could be 
redeemed for consumable goods at any local Checkers supermarkets, but excluded purchase of 
alcohol or cigarettes. Vouchers began at R25 and incrementally increased in value by R12.50 
with each consecutive methamphetamine-negative test provided, where an additional R100 
bonus was granted following three consecutive methamphetamine-negative tests. This payment 
schedule was based on that of Shoptaw et al.’s (2005) original reinforcement schedule design, 
with a rand-to-dollar conversion rate of R10 to 1$. If a participant was abstinent from 
methamphetamine throughout the entire duration of CM treatment, the participant could 
accumulate a maximum of R4850. However, if the participant presented with a 
methamphetamine-positive urine sample at any point during the CM treatment period, the 
individual lost the opportunity to earn a voucher, and the value of the next voucher that could be 
earned dropped to R25, regardless of the value of their previous voucher. Despite this, a “rapid 
reset” rule was adopted, which allows an individual to return to their highest earned voucher 
previously obtained following three consecutive methamphetamine-negative tests.  
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 Additionally, participants could receive vouchers for demonstrating good performance on 
the BART and IGT, where a participant could receive up to a maximum of R50 (R25 each) on 
both tasks at baseline assessment.  
 Healthy controls. At baseline task assessment, participants were compensated for their 
time with a R150 voucher. Moreover, control participants also stood a chance of earning an 
additional R50 for good performance, defined as receiving an overall positive net return, on both 
the IGT and BART. 
Statistical Analyses 
Under hypothesis 1, I investigated several RDM outcomes including: (a) the magnitude 
effect, defined as the tendency to seek-out large short-term rewards and withstand loss outcomes; 
(b) the frequency effect, defined as the tendency to favour frequent gains and avoid frequent 
losses; and (c) risk learning, defined as the tendency to shift behaviour towards advantageous 
choices that maximise payoffs, in addition to (d) risk-taking propensity, defined as the extent to 
which riskier, variable outcomes are preferred over safer, certain outcomes. Linear mixed-effects 
models (LMM) were used to investigate (a) the magnitude effect and (b) frequency effect in 
addition to risk learning (c) on the IGT. Risk learning was additionally assessed on the BART 
using a generalized linear mixed-effects model (GLMM), whilst risk-taking propensity (a) was 
assessed on the BART using an ANCOVA. Mixed-effects models of risk learning differed 
between the IGT and BART in order to account for differences in task construction. These model 
differences will be discussed under each new section of analysis below. Moreover, the aim of all 
adopted models was to assess potential differences in RDM features between treatment non-
responder, treatment responder and healthy controls.  
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Using covariate identification methods described by Raab, Day and Sales (2000), 
potential confounders of group differences in gambling task performance were defined as 
sociodemographic, individual and/or substance-related factors that substantially differed between 
non-responders, responders and control groups (p<.10), and were substantially correlated (using 
Pearson’s r) with task performance outcomes (p<.10); these were in turn included in the model 
as confounders. Moreover, additional covariates were identified as those sociodemographic, 
individual and/or substance-related factors that did not largely differ (p>.10) between groups, but 
did substantially correlate with performance outcomes; these were included in models where 
major relationships were demonstrated. In order to combat potential model misspecification in a 
small sample, a more liberal alpha p-value of .10 was utilized to increase the power of detecting 
potential covariates. The potential influence of substance use factors on performance, which 
were exclusive characteristics of MUD participants, were investigated in models that included 
MUD participants only.  
 Moreover, for both tasks, all models with significant or trending findings were followed 
by group contrasts in order to assess potential differences in RDM features between non-
responder, responder and control subgroups, using Tukey’s p-adjustment correction method. 
Group contrasts were used to minimize type-1-error associated with multiple group comparisons. 
Both p-values and effect sizes were presented, where in the case of significant (p <.05) or trend-
level (.05 ≥ p ≤.10) differences, effect sizes were drawn upon to interpret the likely robustness of 
obtained results. This approach was adopted considering that significance tests are relatively 
more sensitive to sample size differences (Fritz, Morris & Richler, 2012). When investigating 
effect sizes of between-group contrasts in LMMs, Hedges’ g estimation was utilized based on its 
utility within smaller samples, namely where .20 was interpreted as a small effect, .50 as a 
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medium effect, and .80 as a large effect. When assessing continuous variable relationships in 
LMMs, Pearson's r was utilized as the effect size, where .10 was regarded as a small effect, 
followed by .30 as medium and .50 as large effect. Both estimations were based on Cohen’s 
(1988) conventions. An additional effect size estimation of relative risk or odds ratio was utilized 
for GLMM and related nonlinear models, where 1.68 was considered small, 3.47 medium and 
6.71 large, which is equivalent to Cohen’s (1988) conventions (Chen, Cohen, Chen, 2010). 95% 
confidence intervals were presented with all effect sizes, and all analyses were conducted using 
R programming software (R Core Team, 2018). 
Hypothesis 1a 
MUD participants, treatment non-responders more than responders, demonstrate greater RDM at 
baseline relative to healthy controls; where RDM is defined by several RDM features, including: 
magnitude effect, frequency effect, learning and risk-taking propensity.  
 Given previous reports of within-group heterogeneity in performance on the IGT 
amongst both substance-using and healthy samples (Bechara & Damasio, 2002; Horstmann et 
al., 2012; Verdejo-Garcia et al., 2014), LMM & GLMMs were utilized to account for this. 
Mixed-effect modelling does this by capturing both fixed and random effects, where estimation 
of random effects increases the precision of fixed-effects estimates. Attention was mostly paid to 
fixed-effects, which represented group differences after controlling for potential confounding 
effects of individual-subject variability on performance (i.e. the random effect). All LMM 
models were fitted using restricted maximum likelihood, whilst GLMM was fitted using the 
Laplace approximation of maximum likelihood, considering that the former method is not 
available for GLMM. For LMM model comparisons, models were re-fitted using maximum 
likelihood before being compared with use of a likelihood ratio (LR) test. Moreover, GLMM 
37 
 
models were re-fitted using pseudo-likelihood tests before being compared using pseudo-
likelihood ratio tests. 
Magnitude effect.  
IGT analysis 1.1. Non-responders will demonstrate a greater tendency to seek-out large 
short-term rewards and withstand large short-term losses on the IGT at baseline, relative to 
responders and healthy controls consecutively. 
An LMM was implemented to assess potential differences between non-responders, 
responders and controls in relation to the IGT magnitude effect at baseline. The magnitude effect 
was calculated by subtracting the number of selections from decks associated with large short-
term gains and long-term losses (A & B) from decks tied to small short-term gains and long-term 
gains (C & D), over several blocks (see Table 2). Block scores represented a net sum of 
advantageous relative to disadvantageous deck selections, where blocks each consisted of 20 
trials, spanning from blocks 2-5. However, the first block was removed from analysis given 
that performance on this block reflects more exploratory behavior, relative to latter blocks 
associated with more deliberate decision-making (Gansler, Jerram, Vannorsdall & Schretlen, 
2011). High scores represent a low magnitude effect, as high scores are associated with a 
tendency to seek-out long-term gains tied to smaller short-term gains. In contrast, low scores 
demonstrate a high magnitude effect, as lower scores emerge from a tendency to seek-out large 
short-term gains that are also tied to long-term losses.  
Appropriate when data is hierarchically clustered, the LMM sought to estimate potential 
group differences (fixed-effect) in the magnitude effect whilst simultaneously accounting for 
between-subject variability in block net scores (random effect). More specifically, the block net 
score was modelled as the unit of observation at level-1, accounting for its clustering within each 
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individual participant, where each participant acted as the unit at level-2. If significant (or trend-
level) between-group differences were found between non-responders, responders and controls, 
additional planned comparisons were conducted in order to assess wherein such group 
differences lay within each individual disadvantageous deck, namely decks A and B. The 
purpose of this was to confirm whether group differences were additionally characterized by an 
ability to withstand large short-term losses alongside a drive to seek-out large short-term gains. 
Frequency effect.  
 IGT analysis 1.2. Non-responders will demonstrate a greater tendency to seek-out 
frequent rewards and avoid frequent losses on the IGT at baseline, relative to responders and 
healthy controls consecutively. 
An LMM was run in order to assess potential differences between non-responders, 
responders and control groups in the frequency effect on baseline IGT. The frequency effect was 
measured by subtracting the sum of deck selections associated with infrequent gains and frequent 
losses (A&C) from the sum of deck selections tied to frequent gains and infrequent losses (B&D) 
(Table 2). This scoring method was applied to each block of 20 trials, spanning from blocks 2-5, 
and excluding block 1, for the same reasons presented under IGT analysis 1.1. Moreover, high 
net scores represented high frequency effects, where decks were associated with seeking-out 
frequent gains and avoiding frequent losses. In contrast, low net scores represented low 
frequency effects, demonstrating a tendency to seek-out infrequent rewards and withstand 
frequent losses.   
Similarly to IGT analysis 1.1, the block score was modelled as a level-1 unit of 
observation, with the participant modelled as the hierarchical grouping unit at level-2. Unlike 
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IGT analysis 1.1, no additional planned comparisons of individual decks were run. This was due 
to the fact that decks only varied exactly by two possible combinations: by frequent gains and 
infrequent losses, or infrequent gains and frequent losses. Because of this, the frequency of gains 
over losses could not be investigated separately, and is specific to the version of the task utilized 
in the present study.  
Risk learning.  
IGT analysis 1.3. Non-responders will demonstrate the poorest learning on IGT at 
baseline, relative to responders and healthy controls consecutively. 
Risk learning on the IGT is defined by the extent to which one shifted from or avoided 
disadvantageous, long-term loss decks for more advantageous, long-term payout over the 
duration of the IGT at baseline. More specifically, learning is represented by continual 
improvement in IGT net score across consecutive blocks, whilst a declining or stable score over 
time reflects poor learning on the task. A linear mixed-effects growth curve model (LMM-GC) 
was used to investigate risk learning by assessing potential group differences in the change in net 
score across 5 consecutive blocks on the IGT at baseline. In extension, different growth curves 
(linear, quadratic and cubic) were modeled to determine the most appropriate fit. Importantly, in 
this model the fixed effect was represented by the change in block performance or the individual 
growth curve of each non-responder, responder and control group, whilst the random effect was 
captured as potential between-subject differences in block scores trends.   
Like LMMs described under “IGT analysis 1.1” and “IGT analysis 1.2”, level-1 and -2 
units were consistent across models, with the exception of the block number being modeled as a 
fixed-effect in this particular model, representing a proxy variable of time that allows the change 
in score to be tracked over the duration of the task for each of non-responder, responders and 
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control groups. The model also specified an additional random slope estimate at level-2, 
accounting for potential variability in the slope of the growth curve between individuals. In 
addition to assessing performance over time, post-hoc contrasts were utilized to assess potential 
differences in block-by-block performance within each group. This was done in order to locate 
where the majority of learning took place for each group.  
Table 2       
IGT deck outcome profiles and associated scoring methods   
Deck A Deck B Deck C Deck D Measure  
Magnitude 
effect 
Reward 
magnitude  
High immediate 
reward 
High 
immediate 
reward 
Low 
immediate 
reward 
Low immediate 
reward 
(C + D) – (A + D) 
for each of blocks 
2-5  
Loss 
magnitude  
Intermediate 
immediate loss 
High 
immediate 
loss 
Low 
immediate 
loss 
Intermediate 
immediate loss 
Frequency 
effect  
Gain-loss 
frequency  
Infrequent gain; 
Frequent loss 
Frequent 
gain; 
Infrequent 
loss 
Infrequency 
gain; 
Frequent loss 
Frequent gain;  
Infrequent loss 
(B + D) – (A + C)  
for each of blocks 
2-5 
Risk 
learning 
 
Long-term 
Long-term net 
negative 
Long-term 
net negative 
Long-term net 
positive 
Long-term net-
positive 
(C + D) – (A + D) 
block 5 – block 1 
Note. Decks A & B relate to a high magnitude effect, with a tendency to seek-out large short-term reward and withstand 
large losses. The latter is explicitly verified when B> A.  
Decks A & B also correspond with a lower long-term payout 
Decks C & B relate to a low magnitude effect, with a tendency to avoid large short-term rewards (i.e. seek-out small 
immediate rewards instead) 
Decks B & D relate to a high frequency effect, with a tendency to seek-out frequent rewards and avoid frequent losses  
Decks A & C relate to a low frequency effect, with a tendency to seek-out infrequent rewards and withstand frequent 
losses 
 
BART analysis 1.4. Non-responders demonstrate the poorest learning on the BART at 
baseline, relative to responders and healthy controls consecutively, as demonstrated by relatively 
increased pumping following burst trials. 
A GLMM first proposed by Mata and et al. (2012) was utilized to assess differences in 
learning between non-responder, responder and healthy control groups on the BART at baseline. 
Learning is argued to be exhibited by decreased pumping following burst trials, where evidence 
of learning is indicative of adaptive decision-making. Unlike the LMMs presented, a GLMM 
was required to model learning on the BART given the non-normal distribution of the outcome 
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variable, pumps per trial. In particular, estimates were derived from the gamma distribution using 
log estimation, which was verified through model selection. Given the wide probabilistic range 
of balloon bursts on the BART, with 1/32 and 1/128 representing risky and non-risky balloons 
respectively, there may be considerable variability in subject-level pumping across trials. 
Considering this, the use of GLMM provides a means to explicitly account for such inter-subject 
variability as random effects, in order to increase the precision of fixed-effect group differences 
in learning. In the GLMM, pumps per trial were specified as the unit for level-1 estimates, where 
trial pumps were clustered within subjects, who formed the unit at level-2 of the model.    
Besides assessing potential group differences in learning on the BART at baseline, the 
GLMM additionally accounted for the potential influence of several proposed fixed covariates of 
pumping behaviour on a current trial (Ashenhurst et al., 2014; Dean et al., 2011; Mata et al., 
2012). These included current trial number, current trial burst, previous trial burst and balloon 
colour, where the balloon colour represents the associated riskiness of the balloon. Moreover, the 
model was followed by post-hoc contrasts of pumping differences between previous burst and 
cash-out conditions for each of non-responder, responder and control groups. 
This model differs from LMM-GC learning on the IGT for several reasons. Firstly, the 
GLMM assesses learning as the tendency to alter behaviour following a certain condition, 
namely the burst condition on the BART, whilst the LMM-GC assesses learning as a change in 
score over the entire duration of the IGT. Moreover, the distribution of the outcome that is 
indicative of learning in both models follows different distributions, and thus requires slightly 
altered modelling techniques. The exclusive addition of several unique covariates into the BART 
learning model emerges from previous studies’ work on the model, which represent covariates 
that are specific to the task itself.  
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Risk-taking propensity.  
BART analysis 1.5. Non-responders demonstrate greater risk-taking propensity on the 
BART at baseline, relative to responders and healthy controls consecutively.  
A one-way ANCOVA was utilized to assess potential differences between non-
responders, responders and control groups in risk-taking propensity on the BART at baseline. 
Risk-taking propensity was measured by the average number of pumps on non-explosion trials 
on the BART, otherwise known as the mean adjusted score. Lejuez et al. (2002) argue that a 
mean adjusted score is a valid reflection of true pumping behaviour, given that inclusion of 
pumps on explosion trials may actually underestimate true pumping behaviour. Moreover, an 
ANCOVA model is best suited to investigate risk-taking propensity, as risk-taking propensity 
refers to a relatively stable preference for riskier over safer actions, and preferences can be better 
captured by average performance. Unlike the BART, the IGT is not considered a measure of 
risk-taking propensity, given that risk-taking preferences are confounded by consideration for 
long-term outcomes on the IGT (Schonberg et al., 2011), which are absent in the BART.  
Hypothesis 1b 
Impulsivity positively moderates RDM features at baseline, but does not entirely account for 
potential group differences in RDM. 
In all the models presented under this section, all original models of group differences 
proposed under hypothesis 1 were duplicated to incorporate impulsivity as a moderator of RDM 
features, where impulsivity was represented by the UPPS-P total score. The UPPS-P total score 
was continuous, where high scores reflected higher impulsivity, and lower scores represented 
lower impulsivity. All models assessed the potential main effect of impulsivity in relation to 
various RDM features. Moreover, potential interaction effects between the non-responder, 
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responder and control groups and impulsivity were investigated. In addition, if significant (or 
trend-level) interaction effects were found, a Sobel test was conducted in order to verify that 
impulsivity did not act as a mediator of the relationship between group differences and RDM 
features.  
Hypothesis 2 
Amongst MUD participants, greater RDM, alongside greater impulsivity, predicts relapse 
occurrence and relapse severity over the duration of CM treatment, where RDM is defined by 
average overall performance on IGT and/or BART. 
A hurdle model was utilized to investigate whether RDM predicted CM treatment 
outcomes for MUD participants. CM treatment outcomes included relapse occurrence, which 
was defined as having at least one methamphetamine-positive urine sample and/or a missed 
sample during CM treatment. Treating missed samples as methamphtermine-positive urine 
samples offers a more conservative defintion that has been extenstively adopted in previous 
studies (Correia & Benson, 2006; Petry et al., 2004; Rash et al. 2008), CM treatment was also 
assessed by relapse severity, which referred to the number of methamphetamine-positive urine 
samples, including number of missed samples, obtained out of a total of 24 samples whilst 
undergoing CM treatment, with larger numbers representing greater relapse severity. The hurdle 
model represents both treatment outcomes within a 2-part model consisting of Binomial and 
Poisson processes, where outcomes to treatment were represented by a binomial process up until 
some threshold, following which they were represented by a Poisson process. Specifically, the 
binomial model estimated the odds of one relapsing at least once during CM treatment amongst 
MUD participants, whilst the Poisson model estimated the odds of severe/prolonged relapse 
amongst those who had relapsed at least once (i.e. non-responders only).  
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Moreover, RDM was incorporated as a potential predictor of CM treatment success, and 
was defined by overall average performance on the IGT and/or BART, where a median-split was 
utilized to characterise high and low performers on each task. A dichotomous variable was opted 
for over a continuous one, given that numeric differences in average overall performance may 
not entirely reflect true differences in RDM, but also random variability. Moreover, impulsivity 
was included as a potential covariate, as measured using the UPPS-P total score, because high 
impulsivity has been found to be associated with higher risk of relapse (Pattij & De Vries, 2013). 
Moreover, an additional covariate included the number of methamphetamine-positive urine 
samples during the baseline screening period, which has been previously tied to risk of relapse. 
In a cocaine-using sample, Ehrman Robbins and Cornish (2001) found that a greater number of 
baseline cocaine-positive urine samples was linked to greater relapse likelihood. Potential 
covariates that were considered were limited to impulsivity and methamphetamine-positive tests 
at the baseline screening period, due to their high associated reliability of measurement. With 
several possible predictors considered, only the most parsimonious model was selected using 
model comparison. In other words, a fully specified model was compared to reduced versions in 
order to acquire a model with the most relevant predictors. Models were compared using Akaike 
Information Criterion (AIC).  
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CHAPTER FOUR: RESULTS 
Given that this study predominantly focused on RDM of MUD subgroups based on their 
treatment response on CM, the treatment process and associated outcomes were not analyzed in 
detail under hypothesis 1, but were merely used to define treatment response subgroups, 
specifically non-responders and responders. In fact, non-responders were defined as individuals 
who presented with at least one methamphetamine-positive urine sample and/or missing sample 
during CM treatment. In contrast, responders were defined as those individuals who attended all 
sessions and exclusively presented with methamphetamine-negative urine samples through the 
duration of CM treatment. Of the total sample of MUD participants, 9 represented non-
responders, whilst 17 represented responders. On average, MUD participants provided clean (i.e. 
methamphetamine-negative) urine samples 83 percent of the time during the CM treatment 
period, whilst non-responders provided clean samples 54 percent of the time. Furthermore, non-
responders and responders were investigated in relation to a healthy non-substance-using control 
group of 19 participants. Whilst not investigated under hypothesis 1, the potential relationship 
between RDM and CM treatment outcomes was investigated under hypothesis 2. 
Group Matching on Demographics  
Firstly, matching was assessed between responders, non-responders and control groups in 
relation to several demographic variables that have been previously tied to performance on 
gambling tasks including; gender, education, age and broad intellectual function (i.e. WASI), see 
Table 3 (Bolla, Eldreth, Matochik & Cadet, 2004; Davis et al., 2008; Evans, Kemish & Turnbull, 
2004; Rogers et al., 1999; van den Bos, Homberg & de Visser, 2013; Webb, DelDonno & 
Killgore, 2014; Wood, Busemeyer, Koling, Cox & Davis, 2005). Non-responder, responder and 
controls groups were relatively well matched in gender, age and WASI scores, as they did not 
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significantly differ in these characteristics. In contrast, groups did significantly differ in years of 
education, partly because there was an absence of participants with tertiary education within the 
non-responder group. Moreover, groups significantly differed in impulsivity, with non-
responders exhibiting the highest impulsivity, followed by responders and controls respectively. 
Furthermore, groups significantly differed across various additional sociodemographic factors, 
including current employment and household income (Table 3). More specifically, a larger 
number of non-responders and responders were unemployed at the time of the study than healthy 
controls. Interestingly, responders had the lowest average household income, followed by non-
responders and controls consecutively.  
Covariates of RDM 
No demographic variables substantially (p<.10) covaried with RDM features (see 
Appendix A), except for gender in models of (a) IGT frequency effect (rs = -0.23, p=.001**), (b) 
BART risk-taking propensity (rs = -0.45, p=.002**), and (c) BART learning model (rs = 0.25, 
p<.001***). As a result of this, only the models mentioned above incorporated covariates. 
Furthermore, impulsivity was excluded as a covariate, as it was separately investigated in 
relation to RDM features under hypothesis 1b. Moreover, characteristics that were exclusively 
applicable to MUD participants were compared between non-responders and responders; and 
included; methamphetamine use history, number of methamphetamine-positive baseline urine 
samples, whether or not a MUD participant was already enrolled in outpatient treatment at the 
time of CM enrollment, as well as whether MUD participants were secondary users of either 
methaqualone (mandrax) and/or cannabis or merely primary methamphetamine users (this 
excluded occasional alcohol use and/or cigarette smoking). Only a trending difference (p=.053) 
was found between non-responders and responders in methamphetamine use history, where non-
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responders had a longer duration of methamphetamine use relative to responders. However, 
although methamphetamine use history significantly differed between groups, it did not 
substantially covary (p<.10) with RDM features, and in turn was not included as a covariate in 
any models. 
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Table 3 
Full sample characteristics (N=45) 
Variable Nonrespond
ers 
 (n = 9) 
Responders  
(n = 17) 
Healthy 
Controls 
(n = 19) 
F/χ²  p 
Sociodemographic characteristics      
Age, mean (SD) 34.20 (5.34) 33.76 (6.69) 35.50 (7.12) 0.67 .517 
Gender (M: F) 7:2 10:7 11:8 1.16 .619 
Education (7-10:11-12:13+) 4:5:0 5:6:6 1:11:7 9.15 .035* 
Employment (Y: N) 0:9 4a:12 11:8 10.04 .005** 
Household income (RAND), mean 
(SD) 
45277.78 
(26084) 
14117.65 
(19404) 
34473.68 
(34657) 
4.27 .021* 
Cognitive characteristics       
WASI IQ, mean (SD) 90.44 
(12.00) 
91.47 
(21.55) 
88.89 
(17.00) 
0.09 .913 
Methamphetamine (MA) use history      
Duration of MA use (years), mean 
(SD) 
13.44 (3.71) 9.88 (4.48) -- 4.15 .053+ 
Baseline MA positive, % 45.40 
(24.30) 
36.20 
(19.70) 
 1.08 .307 
Other substance use and concurrent treatment       
Secondary substance (Methaqualone 
&/or cannabis: none) 
7:2 8:9 -- 1.19 .217 
Concurrent outpatient treatment (Y: N) 6:3 9:8 -- 0.07 .683 
Note. Employment = Binary (yes or no) variable representing current employment. a = missing value/s in total 
sample. Household income = Yearly household income variable derived from an ordinal 5 income category 
variable, where average income was extracted from the income range reflected within an income category. 
WASI IQ = aggregate score derived from both verbal and performance subsets of the Weschler-abbreviated 
scale of intelligence test. Baseline MA positive = proportion of MA-positive tests during baseline period prior 
to CM treatment. Secondary substance = binary variable (Methaqualone &/or cannabis or none) indicating 
presence or absence of use of specific secondary substances besides MA. Concurrent outpatient treatment = 
binary variable (yes or no) indicating concurrent participation in motivational interviewing and/or group 
therapy alongside CM. F tests conducted on variables Age, Education, Household income, WASI IQ, Duration 
of MA use and Baseline MA positive. Fisher’s exact tests conducted on count factors including; gender and 
employment, whilst chi-squared tests conducted on Concurrent outpatient treatment and Secondary substance. 
+ p <0.10, * p <0.05, ** p< 0.01, *** p<0.001 
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Main Analyses Findings 
All models met assumptions of normality and homogeneity of variance, expect for the risk-
taking propensity model, which deviated somewhat from normality. Linearity was upheld in all 
models where it is assumed (i.e. all models except IGT and BART learning models). Moreover, 
no highly influential data points were detected in any of the models. For additional model 
comparison findings for Hypothesis 1 and 2, see Appendix B and D respectively.  
Hypothesis 1a. 
Magnitude effect.  
IGT analysis 1.1. The LMM out-performed a random-effects-only model at trending 
significance (LR = 5.09, p =.051), where differences between non-responder, responder and 
control groups (i.e. the fixed-effect) explained a substantial amount of variance in the magnitude 
effect (R2=0.60). These findings provide support for incorporating a group fixed-effect in the 
model. In addition, the LMM significantly outperforming a fixed-effects-only model (LR = 45, p 
<.001***), suggesting the appropriateness of a mixed-effects model in particular. 
Based on specific task specifications relating to short-term reward and loss magnitudes 
on the IGT, the magnitude effect was investigated using separate analyses of reward and loss 
outcomes. Model coefficients (see Table 4) confirm that there was an absence of significant 
group differences between non-responders (m =-5.17, sd= 6.10) and responders (m =-0.53, sd= 
8.80), as well as responders and controls (m =0.79, sd= 7.30). However, in partial support of the 
original hypothesis, a significant group difference was found between non-responders and 
controls (p =.020, Table 4), but following adjustment for multiple group comparisons was found 
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to be a trending significant difference (p=.051) with a large hedges g effect size (g = -0.97) (see 
Table 5). This finding suggests that, at baseline, non-responders demonstrated a greater tendency 
to seek-out decks with larger short-term reward magnitudes over decks with smaller short-term 
reward magnitudes relative to healthy controls. On the other hand, non-responders neither 
differed from responders nor did responders differ from healthy controls, which was contrary to 
that which was initially proposed. However, a medium effect size (g = -0.74) was found between 
non-responders and responders, implying that non-responders might also favour large short-term 
magnitude rewards, although this finding cannot be confirmed. Furthermore, visual inspection of 
the data (Figure 4) provides support for performance differences between non-responders and 
controls, with non-responders showing a greater tendency to seek-out short-term rewards on the 
IGT at baseline.  
 
Figure 4. Magnitude effect and learning on IGT: Differences in average block scores (with 
associated standard error) between non-responders, responders and healthy control groups at 
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baseline, where the size of block scores reflects effects of outcome magnitude on choice 
behaviour, whilst the change in block scores represents extent of learning 
Table 4 
Magnitude effect on IGT at baseline: LMM estimates  
Parameter Estimate CI p 
Fixed effects    
Intercept (NR) β0 -5.16 [-9.18: -1:14] 0.012* 
R β1 
HC β2 
4.63 
5.95 
[-0.43: 9.70] 
[0.97: 10.93] 
0.072+ 
0.020* 
    
Random effects    
Intercept variance α0 29.34   
Error variance σ2ɛ  31.22   
Note. Within MUD group, NR = non-responders and R = responders. HC = 
healthy controls. Estimate = Regression coefficients. CI = 95% confidence 
interval. + p<.10, * p < .05, ** p <.01, *** p <.001.  
 
Table 5 
Magnitude effect on IGT at baseline: Group contrasts from LMM 
 
Eﬀect NR R HC t p G g[CI] 
m(sd) -5.17 (6.10) -0.53 (8.80) 0.79 (7.30)     
Contrast 
NR-HC 
 
 
  
-2.41 .051+ -0.97 [-1.59:-0.19] 
R-HC    -0.64 .794 -0.20 [-0.90: 0.49] 
NR-R    -1.84 .167 -0.74 [-1.37: 0.05] 
Note. Within MUD group, NR = non-responders and R = responders. HC = healthy 
controls. m(sd)= raw mean of specified group with corresponding standard deviation. 
g = hedges g effect size. CI = 95% confidence interval. Tukey’s p-adjustment used to 
correct for group contrasts.  
+ p<.10, * p < .05, ** p <.01, *** p <.001.  
 
 
 
Moreover, in order to assess whether poorer performance on baseline IGT was 
additionally influenced by the magnitude of loss outcomes, the main analysis was followed by 
planned group comparisons conducted within individual decks specifically associated with high 
reward magnitudes, only if significant (or trending significant) group differences were obtained 
in the main model. Given the trending difference found between non-responders and controls in 
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relation to reward magnitude, these groups were further compared in relation to loss magnitude 
(Figure 5). In particular, when non-responders and controls were compared within a deck 
associated with large short-term reward and loss, namely deck B, groups did not significantly 
differ in their ability to withstand large short-term losses (t = 1.20, p = .229, g= 0.51, CI [-
0.30:1.29]). In contrast, non-responders did select deck A significantly more often than controls 
(t =2.50, p = .017* g= 0.99, CI [-0.01:1.88]), a disadvantageous deck that is associated with 
relatively smaller losses to those of deck B. In conjunction, these findings suggest that non-
responders may not differ from healthy controls in their ability to withstand losses. Moreover, it 
is suggestive that the original magnitude effect hypothesis is only partially supported by a 
difference in preference for rewards in particular.  
 
Figure 5. Mean deck selections on IGT: Selections of disadvantageous, low short-term loss deck 
A and disadvantageous, high short-term loss deck B by non-responder and healthy control 
groups at baseline.  
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Frequency effect.  
 IGT analysis 1.2. Providing support for use of an LMM model, it was found to 
significantly outperform a fixed-effects only model (LR=40.00, p=<.001***). Moreover, an 
LMM that included fixed-effects of interest performed significantly better than a random-effects-
only model, suggesting the relevance of selected fixed-effects incorporated in the model (LR= 
6.80, p=.034*). Moreover, the entire model accounted for a substantial amount of variance in the 
frequency effect (R2=0.588).   
Unlike the magnitude effect model, only a single model (i.e. no additional planned 
comparisons) was utilized to investigate the entirety of the frequency effect, as the result of 
mirrored deck frequency characteristics. Whilst non-responders (m = 0.17, sd = 4.62) appeared to 
significantly differ from responders (m = 5.18, sd = 7.46)  according to model coefficients (Table 
6), after adjusting for multiple group comparisons, only a trending difference (p = .053) was 
demonstrated between non-responders and responders with a medium effect size (g =-0.74, Table 
7). This finding suggests that responders sought-out frequent rewards and avoided frequent 
losses relatively more often than non-responders (Figure 6), and aligns with the hypothesis to a 
degree. However, there were no other (trending) significant differences between the remaining 
groups as initially proposed, however, a trending significance was demonstrated between 
females and males in relation to the frequency effect, where females exhibited a greater tendency 
to seek-out frequent rewards and avoid frequent losses than males did (t =2.50, p=.081, 
g[CI]=0.61 [0.00:1.23]).  
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Figure 6. Frequency effect on IGT: Differences in average block scores (with associated 
standard error) between non-responders, responders and healthy control groups at baseline, 
where the size of block scores reflects effects of outcome frequency on choice behaviour.   
Table 6 
Frequency effect on IGT at baseline: LMM estimates  
Parameter Estimate CI P 
Fixed effects    
Intercept (N) β0 0.16 [-2.89: 3.23] 0.914 
R β1 
HC β2 
5.00 
3.20 
[1.14: 8.87] 
[-0.59: 6.99] 
0.012* 
0.096 
    
Random effects    
Intercept variance 16.74   
Error variance  19.53   
Note. Within MUD group, NR = non-responders and R = responders. HC = 
healthy controls. Estimate = Regression coefficients. CI = 95% confidence 
interval. + p<.10, * p < .05, ** p <.01, *** p <.001.  
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Table 7        
Frequency effect on IGT at baseline: Group contrasts from LMM  
Eﬀect NR R HC T P G g[CI] 
m(sd) 0.17 (4.62) 5.18 (7.46) 3.37 (4.89)     
Contrast 
NR-HC 
 
 
   
-1.45 .323 -0.82 [-1.54: 0.06] 
R-HC    1.21 .454 0.36 [-0.09: 1.00] 
NR-R    -2.40 .053+ -0.74 [-1.31: -0.11] 
Note. Within MUD group, NR = non-responders and R = responders. HC = healthy controls. m(sd)= 
raw mean of specified group with corresponding standard deviation. g = hedges g effect size. CI = 
95% confidence interval. Tukey’s p-adjustment used to correct for group contrasts.  
+ p<.10, * p <.05, ** p <.01, *** p <.001.  
 
Risk learning.  
IGT analysis 1.3. A quadratic LMM-GC was found to model learning better than either 
linear or cubic versions, suggesting that learning on IGT is a nonlinear process (see significant 
quadratic term in Table 8). The LMM-GC also significantly outperformed a random-effects-only 
model (LR=17.00, p =.007*), suggesting that selected fixed-effects are relevant in the model. 
Moreover, the LMM-GC was significantly improved over a fixed-effects-only model (LR=65.00, 
p <.001***) confirming the appropriateness of LMM-GC in model learning.  
In order to assess learning on the IGT, the LMM-GC was utilized to estimate learning 
curves of each of the non-responder, responder and control groups, which represented the change 
in performance over time. Partly supportive of the hypothesis, a trending significant difference in 
learning was demonstrated between non-responders (m = -1.11, sd =7.90) and controls (m =6.32, 
sd = 12.50) both before and after multiple comparison adjustment (p = .066 & p = .081 
respectively, see Tables 8 & 9), with a medium effect size (g = -0.63).  More specifically, 
findings indicate that non-responders exhibited compromised learning relative to healthy controls 
(Table 9, Figure 4). No other (trending) significant group differences were obtained (Table 9). 
When investigating potential block-by-block improvement, healthy controls exclusively 
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exhibited significantly improved performance across blocks, specifically from block 1 to block 3 
and block 1 to block 4 (b3-b1: t = 2.92, p =.030*, g[CI]= 0.62[0.18:0.94]; b4-b1: t =3.10, p 
=.010*, g[CI]= 0.63[0.16:0.93] respectively) (Appendix C).  
Table 8 
Risk learning on IGT at baseline: LMM-GC estimates  
Parameter Estimate CI P 
Fixed effects    
Intercept (NR) β0 -6.60 [-11.66: -1.53] 0.010* 
Block2 β1 -0.41 [-0.81: -0.02] 0.039* 
Block β2 2.09 [-0.79: 4.98] 0.154 
R β3 
HC β4 
-1.80 
-1.09 
[-7.16: 3.55] 
[-6.34: 4.16] 
0.500 
0.677 
Block*R β5 
Block*HC β6 
1.75 
1.87 
[-0.28: 3.79] 
[-0.12: 3.87] 
0.091+ 
0.066+ 
Random effects    
Intercept variance α0 13.59   
Block variance σ2B  3.75   
Error variance σ2ɛ  25.33   
Note. Within MUD group, NR = non-responders and R = responders. HC = 
healthy controls. Estimate = Regression coefficients, Block2 = quadratic 
growth term. Block = linear growth term. CI = 95% confidence interval. + 
p<.10, * p < .05, ** p <.01, *** p <.001.  
 
Table 9        
Risk learning on IGT at baseline: Group contrasts from LMM-GC 
Eﬀect NR R HC t P G g[CI] 
m(sd) -1.11 (7.90) 6.00 (8.80) 6.32 (12.50)     
Contrast 
NR-HC 
 
 
   
-2.20 .081+ -0.63 [-1.21: 0.01] 
R-HC    -0.63 .801 -0.02 [-0.65: 0.62] 
NR-R    -1.65 .235 -0.80 [-1.45: -0.05] 
Note. Within MUD group, NR = non-responders and R = responders. HC = healthy controls. m(sd)= 
raw mean of specified group with corresponding standard deviation. g = hedges g effect size. CI = 
95% confidence interval. Tukey’s p-adjustment used to correct for group contrasts.  
+ p<.10, * p <.05, ** p <.01, *** p <.001.  
 
 
BART analysis 1.5. Utilizing a pseudo-likelihood ratio test, the GLMM significantly 
outperformed a random-effects-only model (χ2= 332, p=<.001**), suggesting that selected fixed 
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effects are appropriate in the model. Moreover, the GLMM was significantly improved over a 
fixed-effects only model (χ2= 679, p=<.001**), confirming the utility of a generalized mixed 
effect model. Using pseudo-R squared estimation, 0.22 of total variance was explained by the 
model. 
Despite model relevance, non-responders (m =12.59, sd = 10.80) were equally at risk of 
increasing pumping following a burst trial than responders (m =11.78, sd = 9.90) or controls (m 
=14.30, sd = 16.10, Table 10 & 11). This finding suggests a lack of differences in learning 
between groups, which does not align with the original hypothesis. On the other hand, several 
model covariates significantly predicted trial pumps, namely: trial number, current burst trial, 
balloon type and gender (Table 10). More specifically, incrementally increased pumping was less 
likely with each subsequent trial (p <.001); increased pumping was less likely to occur on a 
current burst relative to current cash-out trials (p <.001); pumping was more likely to increase 
within riskier red balloons relative to safer, blue balloons, (p <.001); and males exhibited a 
greater likelihood of demonstrating increased pumping relative to female participants (p =.001). 
Furthermore, when investigating potential within-group differences in pumping behavior 
between burst and cash-out conditions, neither significant differences between conditions were 
found within non-responders (p =.214; RR = 1.09 [0.94:1.26]) nor responders (p =.381; RR = 
1.04 [0.94:1.17]). However, a trending significant difference between pumping across burst and 
cash-out conditions was found amongst healthy controls (p =.072; RR = 1.09 [0.99:1.20]), where 
controls pump higher on cash-out relative to burst conditions. In turn, this finding may suggest 
that only control groups differentiate pumping behaviour based on burst or cash conditions.  
 
 
58 
 
Table 10 
Risk learning on BART at baseline: GLMM estimates  
Parameter Estimate CI p 
Fixed effects    
Intercept (NR) β0 -1.81 [1.27: 2.25] <0.001*** 
Trial β1 -0.13 [-0.19: -0.06] <0.001*** 
Current Balloon Burst β2 -0.27 [-0.43: -0.10] <0.001*** 
Previous Balloon Burst β3 
Red Balloon β4 
-0.09 
0.32 
[-0.48: 0.26] 
[0.17: 0.44] 
0.218 
<0.001*** 
Male β5 
R β6 
0.46 
0.01 
[0.10: 0.82] 
[-0.46: 0.49] 
0.001** 
0.964 
HC β7 0.09 [-0.41: 0.56] 0.620 
R*Previous Balloon Burst β8 
HC*Previous Balloon Burst β9 
0.04 
0.00 
[-0.48: 0.54] 
[-0.42:0.44] 
0.650 
0.997 
Random effects    
Intercept variance α0 0.07   
Error variance σ2ɛ  0.30   
Note. Within MUD group, NR = non-responders and R = responders. HC = 
healthy controls. Estimate = Regression coefficients. CI = 95% confidence 
interval. + p<.10, * p < .05, ** p <.01, *** p <.001.  
Risk-taking propensity.  
BART analysis 1.6. A one-way ANCOVA model of risk-taking propensity significantly 
outperformed a null model in absence of any predictors (LR = 10.00, p=.015*), confirming 
appropriateness of model. Moreover, the model explained 0.23 of total variance in the model. 
Unlike LMMs and GLMM that were utilized to model relatively dynamic features of 
RDM, an ANCOVA was used to investigate a relatively more stable preference, risk-taking 
propensity, by assessing pumping behaviour on the BART on average. Contrary to the 
hypothesis, non-responders (m = 12.20, s =6.80), responders (m = 11.25, sd =6.00) and controls 
(m = 12.45, s = 7.80) did not differ in risk-taking propensity on the BART (p = .084, see Table 
11). Interestingly, gender was significantly related to risk-taking propensity on baseline BART, 
where males (m =14.30, sd =7.45) pumped more on average than females (m =8.08, sd =3.05, p 
= .002). 
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Table 11 
Risk taking propensity on BART at baseline: ANCOVA estimates  
Parameter Estimate Df p 
Intercept β0 161.94 1 <0.001*** 
Groups β1  0.17 2 0.841 
Gender β2 10.43 1 0.002** 
Note. Groups = consists of 3 levels: non-responders, responders and healthy controls. 
Estimate = F-statistic. df = degrees of freedom. + p<.10, * p < .05, ** p <.01, *** p 
<.001.  
Hypothesis 1b. 
Magnitude effect. 
IGT analysis 2.1. Contrary to the hypothesis, no significant interaction was established 
between UPPS-P total score and non-responder, responder and control groups in relation to the 
IGT magnitude effect at baseline (F=0.00 p =.994), suggesting that impulsivity does not 
moderate magnitude effects between specific groups. However, as a main effect, impulsivity was 
significantly associated with the IGT magnitude effect (t =-2.40, p=.019*, r[CI] = -0.38 [-0.42:-
0.35], where higher levels of impulsivity were associated with a tendency to seek-out high gains 
(i.e. lower score) across groups. However, when impulsivity was entered as a covariate along 
with non-responder, responder and control groups, the difference in magnitude effect between 
non-responders and healthy controls no longer trended towards significance (p =.168). This 
could be the result of additional error variability contributed by the inclusion of impulsivity in 
the model.  
Frequency effect. 
IGT analysis 2.2. No significant interaction was seen between non-responder, responder 
and control groups and UPPS total score in relation to the IGT frequency effect at baseline 
(F=0.14 p = .864), implying that impulsivity does not moderate group differences in the 
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frequency effect, and fails to support the hypothesis. Moreover, when investigating the potential 
main effect of UPPS total score on the frequency effect, it was not found to be associated with 
the frequency effect (t =-0.96, p=.339, r[CI] = -0.11 [-0.14: -0.09].  
Risk-learning. 
IGT analysis 2.3. Contrary to the initial hypothesis, impulsivity was found not to 
moderate differences in learning between groups on the IGT, as found by the lack of a significant 
interaction effect between groups and UPPS total score (F =0.00 p =0.999). Moreover, UPPS-P 
total score was not significantly associated with learning, when incorporated as a main effect (t 
=-1.13, p=.262, r[CI] = -0.20[-0.24:-0.17]), suggesting that learning on the IGT and impulsivity 
are likely unrelated. 
 
BART analysis 2.4. There was no significant interaction found (F =1.08 p =.523) between 
groups and UPPS-P total score in relation to pumping following burst trial condition on the 
BART. This finding indicates that impulsivity did not contribute to moderating learning between 
groups, and thus does not support the original hypothesis. Moreover, when assessing the 
potential main effect of impulsivity on pumps following previous burst trials, impulsivity did not 
impact pumping following burst trials (z = 0.55, p=.579, RR[CI] = 1.04 [0.89:1.21]).  
Risk-taking propensity.  
BART analysis 2.5. No significant interaction was found between groups and UPPS-P 
total score in relation to risk-taking propensity on the BART at baseline (F =0.78 p =.466), 
which indicates that impulsivity does not moderate risk-taking propensity between groups. 
Moreover, this finding does not provide support for the original hypothesis. Furthermore, no 
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relationship was established between impulsivity and risk-taking propensity when entered into 
the model as a main effect (t =0.14, p=.888, r[CI] = 0.00[-0.00:0.01]).  
Hypothesis 2. 
CM treatment effect analysis 3.1. Of model comparisons (see Appendix D), the selected 
parsimonious hurdle model performed significantly better than a null model in absence of 
predictors (LR = 39.40, p=<.001***), and 0.42 of total variance was explained by the model. 
Assessing the likelihood of relapsing on CM, the zero-inflated model component highlighted that 
higher impulsivity significantly predicted greater odds of relapse during CM (p = .035), although 
the effect size was small (OR = 1.10, Table 12). Moreover, average IGT performance was not 
significantly related to risk of relapse (p -.108, Table 12). On the count hurdle component that 
modelled the likelihood of increased severity of relapse on CM, a trending significant difference 
was demonstrated between average IGT performance and likelihood of severe relapse (p =.071, 
Table 12). Specifically, poorer average IGT performance was associated with a greater 
likelihood of experiencing severe relapse during CM, although the effect size was small (OR = 
1.80). Additionally, a greater number of methamphetamine-positive tests at baseline was 
significantly predictive of greater odds of severe relapse (p = .005), with a small effect size (OR 
= 1.30, Table 12).  
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Table 12 
Hurdle prediction model of CM treatment effect 
 MUD participants (n= 24a) 
Contrasts z P OR [CI] 
Relapse occurrence 
(zero-hurdle) 
   
Intercept -15.00 .024* 0.00 [0.00:0.13] 
H-IGT 2.50 .108 12.00 [0.57:262.51] 
IMP  0.11 .035* 1.10 [1.00:1.25] 
Baseline MA pos tests 0.16 .697 1.20 [0.51:2.74] 
Relapse severity 
(count-hurdle) 
   
Intercept 3.36 .008** 2.90 [2.40:351.95] 
H-IGT 0.56 .071+ 1.80 [0.95:3.22] 
HI  -0.01 .157 0.98 [0.96: 1.01] 
Baseline MA pos tests 0.26 .005** 1.30 [1.10:1.57] 
Note. H-IGT = poor average performers on IGT; where a median split of total IGT 
score was used to generate a binary categorization, with low scores reflecting 
poorer average performance (n=14) and high scores reflecting better average 
performance n=11). IMP = Vulnerability to impulsive behaviour as measured by 
UPPS-P total score, where higher values reflect higher vulnerability. Baseline MA 
pos tests = number of methamphetamine-positive urine samples during the 2-week 
baseline period prior to CM treatment. Odds refers to the odds ratio. g refers to 
hedges g effect size. CI refers to odds ratio confidence interval.  
a One major outlier removed from analysis (i.e. 1 MUD participant) 
+ p<.10, * p <.05, ** p <.01, *** p <.001.  
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CHAPTER FIVE: DISCUSSION 
The current study was defined by three primary aims. The first of these aims was to 
investigate baseline differences in RDM between non-responders, responders and healthy 
controls, as characterized by several RDM features, including magnitude effects, frequency 
effects, learning and risk-taking propensity. The results showed that non-responders were more 
likely to favour short-term outcomes of a larger reward associated with long-term losses than 
healthy controls (at trend-level significance but with a large effect size), but did not exhibit a 
greater ability to withstand larger short-term losses. Moreover, responders displayed a greater 
tendency to seek-out frequent gains and avoid frequent losses relative to non-responders (at 
trend-level significance but with a medium effect size). In addition, non-responders 
demonstrated compromised learning relative to healthy controls (at trend-level with medium 
effect size), but only on the IGT. In contrast, groups neither differed in learning nor risk-taking 
propensity on the BART.  
The second aim of the study was to assess whether impulsivity exacerbated group 
differences in RDM, for which no moderation effects were found. However, higher impulsivity 
across groups was exclusively related to a tendency to seek-out large rewards despite long-term 
negative consequences.  
The third aim involved assessing whether RDM predicted poor CM treatment outcomes. 
Here, higher impulsivity was found to significantly increase the likelihood of relapse occurring 
(small effect size), whilst poorer overall performance on the IGT significantly increased the 
likelihood of a major relapse during CM treatment (small effect size).  
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RDM Features 
Reward and loss magnitude. On the IGT at baseline, non-responders exhibited a greater 
tendency to favour large short-term rewards than healthy controls, although findings were at 
trend-level significance. A tendency to favour large short-term rewards, specifically on the IGT, 
is also associated with poor performance on the task, as larger short-term rewards are tied to 
long-term losses. Given that the IGT is widely regarded as a measure of adaptive decision-
making in the context of risk-taking (Bechara et al., 1994), a pattern of decision-making that 
reflects a preference for large short-term rewards is suggestive of greater RDM amongst non-
responders relative to healthy controls. In addition, it also suggests that reward magnitude is a 
major driver in decision-making, as it is a characteristic of the potential outcome. These findings 
were consistent with several studies that have investigated IGT performance differences between 
methamphetamine-using and healthy controls, in which MUD participants were found to exhibit 
relatively poorer performance (Gonzalez et al., 2007; van der Plas et al., 2010). 
In contrast, non-responders did not concurrently demonstrate a greater ability to 
withstand large short-term losses in pursuit of large short-term rewards than healthy controls, 
which suggests that RDM by non-responders may be predominantly characterized by a pervasive 
pursuit of reward, rather than a diminished aversion to losses. This is supported by Ahn et al. 
(2014), who found that decision-making deficits of amphetamine users on the IGT were better 
characterized by a sensitivity to rewards relative to healthy controls. Conversely, Vassileva et al. 
(2013) found that a heterogeneous group of substance users demonstrated a tendency to 
withstand losses in pursuit of gains. However, these results were specific to female crack cocaine 
and heroin users, who may differ from both MUD participants and a mixed-sex sample. 
Evidence of the ability to withstand losses amongst substance users was also supported by 
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Strickland, Beckmann, Rush and Stoops (2017), who found that cocaine users exhibited 
diminished loss sensitivity relative to normative loss aversion coefficients represented from non-
clinical populations. Importantly, contrasting findings presented in the aforementioned studies 
may be the result of alternative analytical methods, including the use of computational methods 
of reinforcement learning models (Vassileva et al., 2013), in addition to use of differing risk-
taking tasks such as the mixed gambles task (Strickland et al., 2017).  
However, determining the separable influence of reward and loss outcomes on decision-
making is partially weakened by the inherent complexity of the IGT, reflected in the 
simultaneous display of reward and loss outcomes associated with each deck selected/decision 
made. Moreover, the impact of short-term reward on decision-making can be fairly easily 
observed, given that the reward magnitude presented within each deck is fixed, only varying 
across different decks. On the other hand, loss outcomes can vary in their presentation both 
within and across each deck, fluctuating in frequency of occurrence and at times varying in 
magnitude depending on the deck in use. As a result, loss outcomes in RDM are only assessed 
within large short-term reward conditions in order to isolate the impact of large loss from large 
reward. In turn, such differences call for non-equivalent analytical methods for assessing impact 
of reward versus loss outcomes on RDM, and suggest some caution in interpretations of the 
impact of loss outcomes on RDM.  
IGT performance is influenced by short-term outcomes, but it is also confounded by 
long-term associated outcomes. Poor performance on the IGT can result from both a fixation on 
short-term rewards or a general insensitivity to future consequences (Bechara et al., 2002). 
However, using a variant of the IGT task that inverted reward and punishment schedules, 
Bechara et al. (2002) confirmed that performance by substance users on the IGT was only 
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impaired when large, long-term losses were tied to large short-term gains. This finding highlights 
that substance users are unlikely to be merely insensitive to all types of future consequences, but 
rather fail to account for negative future consequences specifically in the context of large short-
term gains. This supports the interpretation of impaired performance demonstrated by non-
responders as a reflection of RDM in the form of a tendency to select large short-term rewards.  
On the other hand, responders did not differ from healthy controls in their preference for 
large short-term rewards, and because of this, difference in the ability to withstand large short-
term losses was also not confirmed. The absence of a group difference could suggest that 
responders have relatively intact decision-making, given that healthy control samples typically 
demonstrate advantageous decision-making on the IGT (Bechara et al., 1994; Grant et al., 2000). 
However, the direction of differences (qualitatively speaking) aligned with the hypothesized 
direction, namely that responders exhibited a marginally poorer performance relative to healthy 
controls, which could suggest that group differences exist but are not picked up due to an 
underpowered sample size. Interpretation of findings is limited due to the fact that no study, to 
the best of my knowledge, has assessed IGT performance differences between treatment 
responders against a healthy comparison group. 
In addition, responders did not differ from non-responders in their preference for large 
short-term rewards, whilst differences in the ability to withstand losses could not be confirmed. 
Despite this, non-responders displayed the greatest preference for large short-term rewards out of 
the 3 groups, and the direction of group differences between all three groups were as proposed, 
with non-responders performing most poorly, followed by responders and healthy controls. The 
lack of major group differences may suggest that non-responders do not differ from responders 
in decision-making as influenced by the magnitude of reward and loss outcomes, but also that 
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real differences are left undetected in a relatively small sample study. Preliminary research 
provides support for the latter interpretation: in a relatively larger sample study consisting of 75 
cocaine users, Schmitz et al. (2009) found that abstinent cocaine users demonstrated better 
performance on the IGT at baseline relative to non-abstinent cocaine-users. In addition, several 
studies have found a subgroup of substance-users that fail to exhibit decision-making 
impairments on the IGT (Bechara & Damasio, 2002; Verdejo-Garcia et al., 2014; Verdejo-
Garcia, Bechara, Recknor & Perez-Garcia, 2006), and it may be possible that individuals who 
respond to treatment might also fall into this subgroup. Furthermore, the tendency to pursue large 
short-term rewards despite long-term losses amongst non-responders in particular may be 
explained by mechanisms illustrated by premorbid and substance dependency theories, namely 
through reward and loss sensitivity.  
 Reward and loss sensitivity. A pervasive preference for large short-term rewards and 
ability to withstand large losses within substance-using populations has been argued to partially 
result from underlying deficits in sensitivity to both reward and loss respectively, which emerge 
as both a premorbid vulnerability and consequence of chronic substance use (Verdejo-Garcia, 
Perez-Garcia et al., 2006). However, findings from the present study suggest that MUD 
populations are impacted by a heightened sensitivity to reward rather than a diminished 
reactivity to losses. This result was further supported by Ahn et al. (2014), using an 
amphetamine-using sample. Within the same study, a heightened reward sensitivity was 
proposed to be substance-specific, given that opiate users demonstrated a diminished loss 
sensitivity relative to healthy controls (Ahn et al., 2014). On the other hand, using both the 
original and variant IGT task, Bechara et al. (2002) determined that two-thirds of a heterogenous 
alcohol, cocaine and methamphetamine sample performed more poorly on the original IGT as a 
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result of increased sensitivity to large rewards, which suggests that deficits in reward sensitivity 
may be a major component across all substance types. However, it is possible that different 
substance-types drive different effects within Bechara et al. (2002) study, considering that the 
study did not account for the possibility of varying decision-making deficits by substance-type. It 
is also possible that all chronic users demonstrate reward sensitivity despite substance type, but 
vary in loss reactivity.  
 In the present study, given that non-responders exhibited RDM that was in part 
characterized by a pervasive drive for large short-term rewards, heightened reward sensitivity is 
suggested. This is argued to emerge from both concurrent neurobiological reward-cue 
sensitization and reward desensitization. In relation to reward-cue sensitization, the incentive-
sensitization theory represents the “wanting” component of deficient reward processing, and 
asserts increased sensitization to drug-cues with prolonged substance use (Robinson, Fischer, 
Ahuja, Lesser & Maniates, 2015). In this way, IGT outcomes associated with large short-term 
rewards may act as drug-cues that bias future decision-making towards decks that are typically 
associated with these outcomes, particularly amongst non-responders. These outcomes can be 
regarded as drug-cues given that they reflect monetary rewards, which represent a means by 
which drugs can be obtained (Sweitzer et al., 2016). Although outcomes on the IGT still only 
reflect hypothetical monetary rewards, performance on the task is additionally validated by the 
promise of a monetary reward tied to good performance on the IGT above a minimum threshold.  
A heightened reward sensitivity may also be the result of reward desensitization 
mechanisms described by the opponent process theory. The “b-process” of opponent process 
theory explains why large rewards are preferred over small rewards. Neurobiological 
desensitization described by the “b-process” is associated with a diminishing hedonic state as a 
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consequence of prolonged drug use, which can extend to drug-related rewards. In order to 
combat this, increasingly large rewards are sought after in order to maintain or heighten hedonic 
experience, which act as a form of positive reinforcement. Additionally, the “a-process” of the 
opponent process theory may also partly explain why a diminishing hedonic effect is exhibited 
for drug and drug-related rewards. This process asserts that neurophysiological processes 
associated with maintaining homeostasis are disrupted with chronic use, and generate 
unregulated aversive phenomenological states typically referred to as withdrawal states in 
Substance Use Disorder. The “b-process” theory posits that presence of such an unregulated, 
aversive state may drive one to pursue the use of a substance in order to suppress this state, 
acting as a form of negative reinforcement. This theory can arguably be extended to include 
drug-related cues, such as monetary rewards. Given that non-responders demonstrated a more 
pervasive drive towards large short-term rewards relative to healthy controls and responders 
(qualitatively speaking), it might be suggested that non-responders present with the greatest 
neurobiological deficiencies regarding reward processing and sensitivity.  
As previously outlined, diminished loss sensitivity has also been proposed to partly 
underlie RDM amongst substance-using populations, and has been reported in substance-using 
samples (Strickland et al., 2017; Gowin, Stewart et al., 2013). In fact, like heightened reward 
sensitivity, a diminished loss sensitivity may also partly emerge from the “b-process” of 
opponent process theory. The unregulated, aversive state generated by chronic substance use and 
described by the “b-process” theory may actually allow one to better withstand additional harm 
or loss, given that marginal losses are experienced as less aversive on top of an existing aversive 
state. This pervasive, aversive state is thought to translate into RDM by extending diminishing 
sensitivity from drug-loss to drug-related loss. Contrary to current theory on Substance Use 
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Disorder and RDM, no major group differences were found in the ability to withstand large 
short-term losses in the current study. This finding may be explained by less apparent 
physiological withdrawal symptoms amongst stimulant users relative to non-stimulant users, 
especially opiate users (Lago & Kosten, 1994). This could suggest that stimulant-specific 
associated neurobiological alterations have less of an impact on withdrawal states, thus 
minimizing disruption of loss processing functions. However, MUD individuals typically exhibit 
dysregulation in the form of aversive affective symptoms (Zorick et al., 2010), which could 
suggest that diminished loss aversion may exclusively impact emotional dysregulation over 
RDM. In contrast, healthy populations demonstrate a greater aversion to losses than do 
individuals with Substance Use Disorder, and are typically more sensitive to losses than rewards 
of the same size (Strickland et al., 2017; Tversky & Kahneman, 1992). 
Loss sensitivity in healthy populations. Differences in decision-making between non-
responders, responders and controls are potentially confounded by the influence of loss aversion 
in biasing decision-making amongst healthy individuals. It was originally presumed that healthy 
individuals would demonstrate adaptive decision-making by shifting over time to decks 
associated with higher long-term rewards on the IGT (Bechara et al., 1994). There is evidence to 
suggest that loss aversion may also drive performance on the IGT amongst healthy samples. 
Weller, Levin and Bechara (2010) found that healthy individuals subjectively outweighed short-
term losses over gains on the IGT. Evidence of loss aversion amongst healthy individuals may 
disrupt good performance on the IGT, and in turn may partly explain the considerable variability 
in performance on the IGT demonstrated within healthy samples (Horstmann et al., 2012; Bull et 
al., 2015). Besides the influence of the magnitude of outcomes, the frequency at which those 
outcomes occur has also been shown to influence decision-making.  
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  Healthy and clinical populations have been shown to be influenced by more than just the 
magnitude of outcomes: the frequency of such outcomes is also relevant. In terms of healthy 
samples, Horstmann et al. (2012) demonstrated that decision-making in healthy individuals on 
the IGT was more influenced by the frequency of short-term rewards than the long-term net 
value. Individuals exhibited a greater tendency to opt for frequent rewards despite long-term 
consequences, and this was supported by findings from Chiu et al. (2008). In the context of 
clinical samples, Brown et al. (2015) demonstrated that amongst schizophrenic patients, 
decision-making on the IGT was influenced by outcome frequency, where schizophrenics were 
found to avoid decks with frequent punishment similarly to controls. Considering the widespread 
influence of effects of frequency in various populations, this may suggest that substance-using 
populations are also influenced by the frequency at which outcomes occur, although to the best 
of my knowledge no previous study has investigated frequency effects in a MUD sample.  
Reward and loss frequency. A major group difference in the effect of frequency was 
demonstrated between non-responders and responders on the IGT, albeit with trend-level 
significance but with a medium effect size. Responders demonstrated a greater tendency to 
favour frequent rewards and avoid frequent losses relative to non-responders, suggesting that 
responders are differentially influenced by outcome frequency than non-responders. This finding 
stood in contrast to the hypothesized direction, which proposed that non-responders would be 
relatively more inclined towards favoring frequent rewards and avoiding frequent losses than 
responders. The unexpected direction of group differences may be explained by the fact that 
frequency effects can be considered a “moderate” feature of RDM in the context of IGT 
performance. To be more specific, whilst seeking frequent gains and avoiding frequent 
punishment appears to be superior to a pattern of seeking-out large immediate rewards in spite of 
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long-term losses, this particular style of decision-making is not entirely optimal on the IGT, 
where short-terms losses and rewards need to be considered in relation to how they relate to 
long-term rewards. In particular, achieving long-term gains on the IGT was not best acquired by 
using a decision-making strategy that favoured the frequency of outcomes. In turn, a greater 
inclination towards frequent rewards and an avoidance of frequent losses may suggest that 
responders are less impaired in RDM than non-responders, although the groups did not 
significantly differ in the magnitude effect, so this idea cannot be confirmed.  
The effect of frequency demonstrated by responders may suggest that responders are 
sensitized to reward, like non-responders, but tend to favour the increased occurrence of reward 
rather than large rewards. However, given that pairs of decks on the IGT vary only by two 
combinations, with either frequent gains and infrequent losses or infrequent gains and frequent 
losses, one cannot assess how reward and loss frequency individually contribute to performance 
by responders in the current study. As a result, it is not clear to what extent decision-making by 
responders may be driven by reward over loss frequency.  
Furthermore, a lack of group differences in effects of frequency between healthy controls 
and non-responders as well as responders might confirm an absence of differences in MUD 
participants and healthy controls with regards to effects of frequency. However, this explanation 
appears to be unlikely given a medium effect size between responders and healthy controls, and 
is especially true when comparing non-responders to healthy controls, where a large effect size 
was illustrated. In the latter case and in contrast to the initial hypothesis, healthy controls 
favoured frequent rewards and avoided frequent losses more often than non-responders. This is 
supported by the Deck B phenomenon. First proposed by Lin, Song, Lin and Chiu (2012), the 
Deck B phenomenon describes a notable preference for the disadvantageous deck B over other 
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decks on IGT within healthy samples, which is inconsistent with task assumptions that healthy 
individuals will avoid selecting disadvantageous decks. The authors argue that this phenomenon 
is due to the influence of highly frequent rewards and infrequent losses associated with this 
particular deck, which differs from deck A, another disadvantageous deck that healthy controls 
tend to successfully avoid. Evidence for the Deck B phenomenon suggests that a real group 
difference may exist between non-responders and healthy controls, but this may not be detected 
within the current study as a result of a relatively small sample size. 
Unlike effects of magnitude in decision-making, which have clear ties to deficits in 
reward and loss sensitivity, it is not entirely clear which neurobiological mechanisms may 
underlie preference for effects of frequency, especially amongst Substance Use Disorder 
populations. One possibility is that responders are sensitized to drug and drug-related cues, but 
are less impacted than non-responders with regards to the severity of neurobiological 
desensitization to reward size, which may drive one to seek-out larger rewards in spite of long-
term losses. Moreover, whilst RDM is represented by a tendency to select certain decks based on 
the magnitude or frequency of associated outcomes, it is also exacerbated by a compromised 
ability to shift from disadvantageous to advantageous decks over time, otherwise referred to as 
risk learning.  
Learning. A trend-level, medium effect size difference in learning was demonstrated 
between non-responders and healthy controls on the IGT at baseline, where non-responders 
exhibited markedly poorer learning. In other words, findings indicate that healthy controls were 
better able than non-responders to avoid selecting disadvantageous decks associated with long-
term loss, and were more likely to opt for advantageous decks tied with greater long-term gains. 
These findings are partly consistent with those reported by Verdejo-Garcia et al. (2007), who 
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found that healthy controls exhibited greater learning on the IGT than substance users. Their 
study included cocaine and marijuana users, rather than MUD participants, which may suggest 
that impairments in learning are present across all substance types. Interestingly though, cocaine 
users demonstrated relatively more compromised learning than marijuana users, which might 
suggest that learning is more severely impacted within stimulant use more broadly-speaking, 
including methamphetamine.  
Additionally, when assessing the rate of learning within-groups, a significant 
improvement in scores across initial block trials was exclusively demonstrated amongst healthy 
controls on the IGT. Such findings provide further evidence of intact learning capabilities 
amongst healthy controls in particular. Moreover, whilst limited improvement in performance 
over time within non-responder and responder groups may confirm compromised learning, it 
may more specifically suggest deficits in delayed learning. In line with this, Verdejo-Garcia et al. 
(2007) found that cocaine users exhibited steeper learning on the second administration of the 
IGT relative to the first, which contrasted with healthy controls who demonstrated steeper 
learning at first administration, suggesting that learning amongst cocaine users was present but 
delayed. In the same study, marijuana users also demonstrated greater learning on the IGT at first 
administration, which may suggest substance-specific effects on learning. 
Moreover, although responders and non-responders did not significantly differ in learning 
on the IGT at baseline, a large effect size was obtained between groups, which suggests that a 
group difference in learning may exist. Specifically, my findings insinuate that responders 
exhibit less compromised learning relative to non-responders. One possibility for a lack of 
significant findings may be an insufficient number of trials to detect maximum learning 
capabilities, as suggested by Overman and Pierce (2013), who found that the addition of trials 
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greater than the standard 100 (as utilized in the current study) is associated with enhanced 
performance.  
Responders did not significantly differ from healthy controls in learning on the IGT at 
baseline, and the effect size was marginal, suggesting that responders might exhibit similar 
learning capabilities to healthy controls. This interpretation is consistent with a graphical 
representation: responders and controls exhibited similar learning curves over the duration of the 
IGT (Figure 5). In support of group differences in learning between both responder and healthy 
control groups relative to non-responders, non-responders appear markedly different from other 
groups, exhibiting relatively stagnated performance, displayed by a flat learning curve.  
No significant differences in learning were established between non-responders, 
responders and healthy controls on the BART at baseline. A lack of group differences lies in 
contrast to a difference in learning found between non-responders and healthy controls on the 
IGT. This is contrary to strong evidence of learning deficits on the BART in substance-using 
populations, including methamphetamine, relative to healthy populations (Kohno et al., 2014). 
Ashenhurst et al. (2014) argue that differences in learning between tasks may be due to 
differences in the tasks themselves, which affect how optimal decision-making is characterized. 
For example, whilst conservative risk-taking (or minimal risk-taking) is always an optimal 
decision-making strategy on the IGT, on the BART it can lead to poor performance through 
marginal accumulated gains, which can alternatively result from excessive risk-taking. Given 
that performance on the BART has been robustly associated with real-world risk-taking 
behaviour (Lejuez et al., 2002), the BART might capture the broader conceptualization of RDM, 
where RDM may refer to actions taken that increase the likelihood of negative consequences or 
the failure to take an action that would likely reap benefits.  
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Recent studies have suggested that substance-using individuals demonstrate 
compromised learning on the BART relative to healthy groups, by failing to learn to take optimal 
risks. In a smoking sample, Dean et al. (2011) found that smokers decreased pumps on high-risk 
balloons over time, whilst non-smokers’ pumping remained stable. Moreover, non-smokers 
conversely increased pumps on low-risk balloons over trials, whilst smokers’ pumping remained 
stable. Therefore, non-smokers obtained a higher net pay-out on the task, suggesting that they 
demonstrate greater adaptive decision-making than smokers, by learning to better maximize task 
pay-outs. Using a similar trial-by-trial learning model, Ashenhurst et al. (2014) found that 
alcohol severity moderated pumps following a large burst trial, where individuals with severe 
alcohol problems took markedly lower risk than those with less severe alcohol problems. 
Findings were similar within MUD samples, and Kohno et al. (2014) found that MUD 
participants pumped less often and earned less than controls, although the former was not 
significant.  
However, preliminary research on learning differences between substance-using and 
healthy samples on the BART does not explain why a lack of significant group differences were 
obtained in the present study. One possibility is that learning deficits do not differ between non-
responders and responders, although this would not explain why healthy controls also do not 
differ. Alternatively, and more likely, the task has high learning demands for all participants. 
Because a considerable amount of MUD participants and matched-controls had education lower 
than tertiary-level, the learning demands of the task may have been too difficult for. This is 
especially relevant when considering that many of studies from which group differences between 
substance-users and healthy controls were obtained consisted only of college samples (Dean et 
al., 2011; Lejuez et al., 2003). Furthermore, Pleskac (2008) found that when learning 
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requirements were reduced on the BART, this increased the ability to distinguish between 
substance-using from healthy control groups, relative to an unaltered version of the task.  
Deficits in learning may be underpinned by some of the same neurobiological 
mechanisms underlying reward sensitivity. In fact, striatal, including amygdala activation, have 
been closely linked to cue-based reinforcement learning (Berridge, 2007; Gowin, Mackey et al., 
2013). This suggests that the same substance-induced alterations to the striatum and other reward 
processing regions that can lead to abnormally heightened sensitivity to reward outcomes may 
also diminish adaptive learning by promoting compulsive reward-seeking. Additional theories of 
both affective and cognitive processes that contribute to learning and adaptive decision-making 
have also been presented in the literature, and were not specifically investigated in the current 
study. This included the somatic marker theory, which asserts that effective decision-making 
(and learning) involves use of internally-driven emotional and visceral signaling to accurately 
bias actions towards long-term positive outcomes. Moreover, other theories assert the importance 
of executive control functions in goal-directed learning, which include working memory, 
cognitive (set) shifting and disinhibition (Schiebener, Zamarian, Delazer & Brand, 2011). Tied to 
this, a two-part systems theory has been proposed to explain how an under-activated “reflective” 
brain system interacts with a hyper-activated “impulsive” system to generate impaired decision-
making amongst individuals with Substance Use Disorder (Bechara, 2005).  
 Risk-taking propensity. Contrary to expectations, neither non-responders nor responders 
differed from healthy controls in risk-taking propensity on the BART at baseline. This finding 
differs from several studies that have confirmed differences in risk-taking propensity between 
substance-using and non-substance-using samples (Hopko et al., 2006; Lejuez et al., 2003; 
Lejuez, Aklin, Bornovalova & Moolchan, 2005). However, more recent studies have found that 
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both at-risk and substance-using samples demonstrate relatively lower pump averages in 
comparison to healthy controls (Ashenhurst, Jentsch & Ray, 2011; Campbell, Samartgis & 
Crowe, 2013), although none of these studies utilized an MUD sample. In addition, Dean et al. 
(2011) found a marginal difference in average pumps between non-smokers and smokers, where 
non-smokers pumped higher than smokers on average. Although this difference was not 
significant, the direction of differences aligned with my study findings, in which healthy controls 
displayed a higher pump average than either non-responders or responders. This finding could 
suggest that non-responders, responders and controls do not differ in risk-taking propensity, 
although it may also be that the BART is not sensitive enough to detect differences. Otherwise, 
BART may not solely measure risk-taking propensity, as supported by Kohno et al. (2014), who 
argue that relatively lower pumping may actually reflect a lack of sustained endurance to 
maximize accumulated pay-out on the BART, or an urgency to acquire immediate rewards.  
Impulsivity and RDM 
Non-responders exhibited significantly greater impulsivity, followed by responders and 
then healthy controls, which aligns with robust literature findings on impulsivity as a relevant 
distinguishing feature of substance-using relative to healthy populations (Verdejo-Garcia et al., 
2008). 
Despite this, impulsivity did not exacerbate performance between groups on any of the 
measured RDM features investigated in the study, suggesting that RDM may not be impacted by 
impulsivity. In a meta-analysis of impulsivity and BART performance in healthy samples, 
Lauriola, Panno, Levin & Lejuez (2013) found large effect sizes for impulsivity and performance 
on the BART, but only for adolescent and young adult samples. In contrast, only small effects 
sizes were obtained for other adult samples, which suggests that impulsivity may play less of a 
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role in the BART amongst adult populations, and supports my study findings. On the other hand, 
impulsivity was significantly associated with the short-term reward magnitude across the groups 
in spite of long-term losses. Given this finding, it was interesting to find that impulsivity did not 
also exacerbate group differences in effects of magnitude. This result may suggest that whilst 
impulsivity is related to effects of magnitude, there is some other pertinent factor/s that 
specifically explains group differences. This factor could potentially refer to specific 
neurocognitive mechanisms underlying RDM. Alternatively, it is also possible that the lack of 
moderation findings may be because of a lack of power to detect moderation effects in a 
relatively small sample size.  
Moreover, a lack of findings also confirms that RDM is likely to be a separable construct 
from impulsivity, the two of which are considered to overlap substantially (Upton et al., 2011). 
Whilst impulsivity has more to do with the speed at which actions are taken or decisions are 
made, generally with little conscious deliberation, RDM determines how probabilities of action-
outcomes are considered. However, RDM can also be impulsively-driven with little thought 
given to outcomes probabilities. The latter case describes typical decision-making by substance-
users, and performance on the IGT and BART is frequently described as tasks of “impulsive 
choice” (Stevens, Goudriaan, Dom, Roeyers & Vanderplasschen, 2015). There is nonetheless 
strong evidence to suggest that impulsivity and RDM are overlapping but independent 
constructs, as suggested by findings from Upton et al. (2011), who established that risk-seeking 
behaviour on the IGT was only evident amongst low and not high impulsivity participants. In 
addition, impulsivity may impact RDM through its presumed effects on learning, as evidenced 
on both the IGT and BART using healthy samples, where high impulsivity groups demonstrated 
relatively poorer learning (Bornovalova et al., 2009; Franken et al., 2008). However, this does 
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not explain why there was an absence of moderating effects on learning models for both the IGT 
and BART in the present study.  
Furthermore, the absence of a strong relationship between impulsivity and RDM in the 
current study may be influenced by the multidimensional nature of impulsivity. Whilst in the 
present study, impulsivity was measured by self-report, it may be that specific aspects of 
impulsivity are more associated with RDM than others. In line with this, and using the same self-
report measure of impulsivity as in the present study, Zermatten, van der Linden, D’Acremont, 
Jermann and Bechara (2005) found that only one specific dimension of impulsivity, lack of 
premeditation, was tied to selection of disadvantageous decks on the IGT in a healthy sample. 
Moreover, impulsivity also exists along behavioural and trait dimensions, which may 
differentially influence RDM, where the current study focused on trait impulsivity through self-
report. Given that the potential impact of different dimensions of impulsivity were not 
investigated in this study, I could not confirm potential issues of multidimensionality of 
impulsivity.  
Sex as a Covariate of RDM 
 RDM features have been found to be additionally influenced by sex differences and years 
of education. Sex was exclusively incorporated as a covariate of RDM for models of frequency 
effect on the IGT, learning and risk-taking propensity on the BART. Of these models, a trend-
level difference in effects of frequency was established between males and females, where 
females exhibited a greater tendency to favour frequent rewards and avoid frequent punishment, 
which is supported in the literature (van den Bos et al., 2013). In addition, sex was significantly 
associated with risk-taking propensity, where males demonstrated a higher pump average than 
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females. This finding aligns with Hunt, Hopko, Bare, Lejuez & Robinson (2005), who found that 
amongst a healthy sample, males displayed greater risk-taking propensity.  
Predictors of CM Treatment Outcomes 
Relapse occurrence. When assessing potential predictors of relapse amongst MUD 
participants over the 8-week CM treatment period, high impulsivity was predictive of a greater 
risk of relapse relative to low impulsivity. This finding is consistent with the literature, where a 
robust relationship has been found between impulsivity and relapse vulnerability within both 
clinical and preclinical samples (Pattij & De Vries, 2013). Despite this finding, the effect size 
was small. Considering that a global measure of impulsivity was utilized to define impulsivity in 
my work, evidence of a small effect size could suggest that specific dimensions of impulsivity 
are better predictive of relapse risk than others. This is supported by a meta-analysis conducted 
by Hershberger, Um and Cyders (2017), who found that specific impulsivity dimensions (lack of 
premeditation and negative urgency) were associated with poorer psychotherapeutic outcomes.   
 Moreover, whilst overall performance on the IGT at baseline was not significantly 
predictive of risk of relapse, the effect size was large. Given that the direction of the relationship 
indicates that poorer IGT performance may be predictive of relapse during CM, it aligns with 
preliminary research. In particular, amongst a cocaine-using sample, Schmitz et al. (2009) found 
that abstinent individuals following 12-weeks of a combined behavioural and 
pharmacotherapeutic intervention demonstrated better performance on the IGT at baseline than 
non-abstinent participants. In addition, Verdejo-Garcia et al. (2014) established that an 
insensitivity to future consequences on the IGT predicted relapse amongst cocaine users 3-
months following testing. However, in a large sample of both MUD and cocaine-users, Adinoff 
et al. (2016) found that baseline performance on the IGT did not predict subsequent relapse 
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during an 8-week 12-step treatment intervention. Comparative interpretations between these 
studies are unfortunately limited due to differences in the treatment interventions chosen.  
Relapse severity. An especially novel finding, MUD participants who performed poorly 
on the IGT at baseline were significantly more likely to demonstrate prolonged relapse (with 
small effect size) during the CM treatment period relative to MUD participants who performed 
better on the IGT. In conjunction with relapse occurrence findings, one could infer that high 
impulsivity may act more as a risk factor for initial relapse, whilst RDM may be directly 
implicated in prolonged relapse, which is indicative of relapse severity and is measured by 
repeated presentation of methamphetamine-positive urine samples. This provides preliminary 
evidence for separate mechanisms underlying minor relapse versus major relapse. Interestingly, 
these findings lie parallel to substance dependence models that distinguish initiation from 
dependence processes. Everitt (2014) argues that impulsivity is strongly associated with the 
initial experimentation of substances, whilst heightened compulsive drug-seeking behaviour 
emerges largely as a consequence of sustained substance use, and perpetuates continued use. 
Thus, in turn, impulsivity mechanisms that are involved in initiation of substance use may also 
be involved in the initiation of relapse, whilst RDM that may in part be worsened by continued 
use of substances may further exacerbate compulsive-drug seeking following initial relapse.  
However, only tentative conclusions can be drawn considering small effect sizes and 
inconsistent literature findings by Adinoff et al. (2016), who found that better performance on 
the IGT at baseline predicted a greater number of stimulant use days at 6 months follow-up. 
However, this inconsistency in findings may likely be due to use of different treatment 
interventions, where Adinoff et al. (2016) used an 8-week 12-step intervention whilst an 8-week 
CM was adopted in the current study. Unlike the 12-step programme, relapse is a direct measure 
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of real-world RDM on the CM, given that relapse (and abstinence) are contingent on foregone 
(and awarded) vouchers as a direct consequence of behaviour. In addition, a greater number of 
methamphetamine-positive tests at baseline were also significantly predictive of a greater 
likelihood of prolonged relapse during CM, in line with previous findings by Ehrman et al. 
(2001) 
Study strengths and limitations  
The current study had several strengths. In particular, MUD participants were primary 
users, with the exception of several individuals who were secondary users of methaqualone 
(mandrax) and/or cannabis usage. To ensure that MUD participants were current users, recent 
methamphetamine usage was verified within a 2-week baseline period before beginning CM 
treatment. This partially eliminated potential confounding effects of length of abstinence on 
gambling task performance. In support, Wang et al. (2013) found that MUD participants with 
longer abstinence periods displayed better performance on the IGT relative to individuals with 
shorter abstinence periods. Moreover, all MUD participants demonstrated verifiable abstinence 
on the day of gambling task baseline assessment, which eliminated any potential acute effects of 
substance use on performance.  
 There are also several limitations in this study. The sample size was relatively small, but 
this pilot study intervention framework of a clinical population has provided sufficient data to 
propose a hypothesis and to calculate samples sizes for more robustly powered work. The 
absence of moderation effects of impulsivity on RDM could not be verified due to this small 
sample size. Groups were not perfectly matched against all potentially relevant 
sociodemographic, individual and substance-related factors that may covary with performance, 
and not all models incorporated covariates. However, steps were taken to increase the precision 
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of model estimates with use of LME models, which account for potential confounding effects of 
individual differences in performance. Furthermore, groups were not examined on executive 
functioning capabilities, which has been strongly tied to performance on IGT (Gonzalez et al., 
2007; van der Plas et al., 2010). As such, group differences in performance may partly be 
explained by executive functioning differences. However, a review by Toplak, Sorge, Benoit, 
West and Stanovich (2010) found that performance on the IGT was weakly related to various 
cognitive capabilities. Finally, a flat rate monetary incentive was used for task performance, 
instead of a performance-sensitive monetary incentive, due to logistical limitations of obtaining 
customized monetary vouchers. However, this flat rate was consistently applied across non-
responder, responder and controls groups, suggesting equal influence on performance across 
groups.  
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CHAPTER SIX: CONCLUSION 
In summary, my findings highlight individual differences in RDM within MUD 
populations, where RDM by responders was particularly influenced by the frequency with which 
outcomes occurred relative to non-responders. Relative to healthy controls, non-responders 
tended to favour the short-term magnitude of rewarding outcomes in spite of their long-term 
negative consequences, and were less capable of learning to adopt adaptive decision-making 
strategies. Higher impulsivity did not exacerbate RDM between groups, but it did predict poorer 
CM treatment success, in conjunction with RDM. In turn, my findings suggest that poorer 
treatment success on CM amongst MUD participants may, in part, be explained by RDM. 
Although larger powered studies would be required to confirm findings, results do suggest that 
MUD individuals at high risk of poor treatment success on CM, may be able to be identified 
prior to commencing CM treatment. Future studies should further investigate which factors 
predominantly drive RDM, and which of these underlying factors is most pertinent to treatment 
outcomes.  
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Appendix A 
 
Table 13          
Correlations between RDM features and sociodemographic, individual and 
substance-related factors 
 IGT 
Magnitude 
effect 
IGT 
Frequency 
Effect 
IGT 
Learning 
BART 
Learning 
BART 
Risk-taking 
propensity 
Age 0.09 0.02 -0.08 0.13 0.14 
WASI IQ 0.27 0.20 0.14 0.11 0.18 
Household Income 0.11 -0.11 0.24 -0.17 -0.08 
IMP -0.35* -0.15 -0.40** 0.10 0.06 
Gender (M: F) -0.02 -0.30** 0.05 0.37* -0.45** 
Race (B:C) 0.05 -0.07 -0.02 -0.02 -0.13 
Education  
(7-10: 11-12: 13+) 
 
0.10 
 
-0.02 
 
0.19 
 
-0.13 
 
-0.20 
Employment (Y: N) -0.08 -0.01 -0.13 -0.05 0.08 
MA Hx 0.08 -0.15 -0.17 -0.03 -0.02 
Baseline MA pos 
tests  
 
0.16 
 
0.24 
 
0.07 
 
-0.24 
 
-0.21 
Outpatient tx (Y: N) 0.12 -0.09 0.20 -0.06 -0.13 
Secondary substance 
(M&C: N) 
 
0.38 
 
-0.10 
 
0.06 
 
0.05 
 
0.07 
Note. Correlations estimated using Pearson’s r. WASI IQ = aggregate score derived from both 
verbal and performance subsets of the Weschler-abbreviated scale of intelligence test. Education 
= separated by 3 subcategories; namely, 7-10 years, 11-12 years and 13+ years education. a = 
missing data. Household income = yearly South African rand-value household income variable 
derived from an ordinal 5 income category variable, where average income was extracted from 
the income range reflected within an income category.  Impulsivity = total score on UPPS-P 
measure of vulnerability to impulsivity (where higher scores represent higher vulnerability). 
Race = defines two racial/ethnic groups; namely black (B) and coloured (C) populations. MA Hx 
= methamphetamine history, measured in years.  Baseline MA pos tests = number of 
methamphetamine-positive urine samples during the 2-week baseline period prior to CM 
treatment. Outpatient tx = whether MUD participants underwent concurrent outpatient treatment 
with CM. Secondary substance = secondary use of methaqualone and/or cannabis relative to pure 
methamphetamine use.  
+ p <.10, * p <.05, * p< .01, ***p<.001 
 
 
Gender was significantly correlated with several RDM features at baseline (Table 13), namely: 
the frequency effect on the IGT, as well as learning and risk-taking propensity on the BART. 
This suggests that gender is likely a relevant covariate of these specific RDM features. 
Impulsivity was also significantly associated with magnitude effect and learning on the IGT, but 
rather than used as a model covariate, was investigated as a potential moderator of group 
differences in RDM features under hypothesis 1b. 
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Appendix B 
Table 14    
Model comparisons for Hypotheses 1a and 1b    
 AIC 
Model  Final 
model 
Fixed-effects 
only model 
Random-effects 
only model 
(1) IGT Magnitude effect  1207 1249 1209 
(2) IGT Frequency effect  1119 1157 1122 
(3) IGT Risk learning  1479 1538 1484 
(4) BART Risk learning  10454 10759 11298 
(5) BART Risk-taking propensity   293 -- 297* 
(5) IGT Magnitude effect & UPPS  1212 1253 1209 
(6) IGT Frequency effect & UPPS  1124 1161 1122 
(7) IGT Risk learning & UPPS  1489 1547 1484 
(8) BART Risk learning & UPPS  10453 11111 11298 
(9) BART Risk-taking propensity & 
UPPS 
 285 -- 301* 
Note. AIC = Akaike Information Criterion. * = In the case of ANCOVA models (i.e. non 
LMM/GLMM models.), final model is compared to an intercept-only model 
 
Table 14 displays the Akaike Information Criterion for final models as well as their associated 
model comparisons, which include fixed-effect only and random-effect only models. In the case 
of BART risk-taking propensity models, the final model is compared to an intercept-only model. 
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Appendix C 
Table 15         
Between-block learning on IGT at baseline 
 T P G g[CI] 
NR     
B2-B1 -0.72 .949 -0.22 [-0.94:0.61] 
B3-B1 0.31 .997 0.10 [-0.52:0.89] 
B4-B1 -1.16 .771 -0.53 [-1.25:0.13] 
B5-B1 -0.32 .990 -0.12 [-0.86:0.66] 
B3-B2 0.97 .860 0.37 [-0.43:0.73] 
B4-B2 -0.60 .970 -0.36 [-1.15:0.42] 
B5-B2 0.25 .999 0.09 [-0.59:0.84] 
B4-B3 -1.62 .486 -1.01 [-1.61: -0.53] 
B5-B3 -0.73 .947 -0.52 [-1.47:0.14] 
B5-B4 1.22 .737 0.55 [-0.09:1.14] 
R     
B2-B1 1.52 .547 0.32 [-0.13:0.68] 
B3-B1 2.52 .090+ 0.57 [0.10:0.98] 
B4-B1 1.90 .318 0.41 [-0.08:0.86] 
B5-B1 2.37 .127 0.64 [0.22:1.03] 
B3-B2 1.24 .725 0.21 [-0.25:0.63] 
B4-B2 0.71 .952 0.12 [-0.36:0.66] 
B5-B2 1.69 .438 0.32 [-0.27:0.89] 
B4-B3 -0.47 .989 -0.07 [-0.53:0.41] 
B5-B3 0.41 .993 0.07 [-0.47:0.50] 
B5-B4 1.21 .743 0.30 [-0.20:0.70] 
HC     
B2-B1 2.63 .068+ 0.61 [0.24:0.96] 
B3-B1 2.92 .031* 0.62 [0.18:0.94] 
B4-B1 3.10 .018* 0.63 [0.16:0.93] 
B5-B1 2.64 .067+ 0.48 [0.00:0.79] 
B3-B2 0.67 .960 0.20 [-0.29:0.69] 
B4-B2 1.04 .833 0.28 [0.17:0.82] 
B5-B2 1.03 .840 0.25 [-0.22:0.64] 
B4-B3 0.44 .991 0.19 [-0.25:0.62] 
B5-B3 0.33 .997 0.07 [-0.44:0.47] 
B5-B4 -0.15 .999 -0.02 [-0.50:0.42] 
Note. Within MUD group, NR = non-responders and R = responders. HC = Healthy controls. B1 
= block 1. B2= block 2. B3 = block 3. B4 = block 4. B5= block 5. g = hedges g effect size. CI = 
95% confidence interval. Tukey’s p-adjustment used to correct for group contrasts.  
+ p<.10, * p <.05, ** p <.01, *** p <.001.  
 
Healthy controls exclusively demonstrated significantly improved performance on the IGT at 
baseline from block 1 to 3, in addition to block 1 to 4 (Table 15). Healthy controls also 
demonstrated a tending significant improvement from block 1 to block 2, as well as from block 1 
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to block 5. Moreover, responders exhibited a trending significant improvement from block 1 to 
block 3, whilst non-responders showed no improvement across blocks.  
Appendix D 
Table 16  
Model comparisons for CM treatment effect 
 MUD participants (n= 24a) 
Model  AIC 
(1) H-IGT  90 
(2) H-IGT+IMP  80 
(3) H-IGT+ Baseline MA pos tests  84 
(4) H-IGT+IMP+ Baseline MA pos tests  76* 
(5) H-BART  92 
(5) H-BART+IMP  83 
(6) H-BART+ Baseline MA pos tests  87 
(7) H-BART+ IMP+ Baseline MA pos 
tests 
 82 
(8) H-IGT+H-BART  92 
(9) H-IGT+H-BART+IMP  84 
(10) H-IGT+H-BART+ Baseline MA pos 
tests 
 87 
(11) H-IGT+H-BART+IMP+ Baseline 
MA pos tests 
 79 
 
(12) IMP+ Baseline MA pos tests  79 
(13) IMP  80 
(14) Baseline MA pos tests  84 
Note. AIC = Akaike Information Criterion. H-IGT = poor average 
performers on IGT; where a median split of total IGT score was used to 
generate a binary categorization, with low scores reflecting poorer 
average performance (n=14) and high scores reflecting better average 
performance n=11). IMP = Vulnerability to impulsive behaviour as 
measured by UPPS-P total score, where higher values reflect higher 
vulnerability. Baseline MA pos tests = number of methamphetamine-
positive urine samples during the 2-week baseline period prior to CM 
treatment. 
a One major outlier removed from analysis (i.e. 1 MUD participant) 
* = Final selected model. 
 
Model 4 was selected as the final model, given that it was associated with the lowest AIC, which 
suggests its parsimony over all other possible models (Table 16).  
 
